data_2hgl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hgl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 36' ' ' ILE . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.411 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 69' ' ' MET . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.804 0.335 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.45 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.052 0.93 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 33' ' ' ASP . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 31' ' ' LEU . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 . . . . . 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.988 0.899 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.652 0.263 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ILE . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.206 0.527 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 122.275 1.036 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.494 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 19' ' ' PRO . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 40' ' ' ALA . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.932 0.872 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 36' ' ' ILE . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' H ' HG21 ' A' ' 46' ' ' ILE . 39.2 m-85 . . . . . 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 64' ' ' GLU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 121.234 0.54 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.616 0.722 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.947 0.404 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.301 0.572 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 121.602 0.715 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 33' ' ' ASP . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HG ' ' HB2' ' A' ' 69' ' ' MET . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.463 ' HB2' ' HG ' ' A' ' 34' ' ' CYS . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.45 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.715 0.769 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 . . . . . 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.439 ' CG1' ' HE2' ' A' ' 87' ' ' LYS . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.882 0.849 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HA ' HG11 ' A' ' 67' ' ' VAL . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.501 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 122.506 1.146 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 ttp -155.68 -32.67 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.264 3.026 . . . . 0.0 110.298 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.56 153.95 51.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.197 2.599 . . . . 0.0 109.615 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.54 -162.11 33.16 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.019 0.768 . . . . 0.0 115.019 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.17 -29.04 1.83 Allowed 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 118.361 1.081 . . . . 0.0 114.663 -2.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.27 169.73 6.25 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.96 2.904 . . . . 0.0 108.748 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.72 49.26 0.22 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 37.53 0.34 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.673 1.606 . . . . 0.0 115.811 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.7 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 1 C-N-CA 133.998 4.919 . . . . 0.0 120.408 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.66 4.61 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.956 1.265 . . . . 0.0 114.676 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -81.94 27.41 0.47 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.956 1.378 . . . . 0.0 113.801 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 36' ' ' ILE . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -140.22 133.97 30.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -67.87 -10.24 51.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.271 87.0 mtt-85 118.29 -0.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 131.9 4.08 . . . . 0.0 112.771 150.115 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.75 -25.51 1.65 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.112 1.765 . . . . 0.0 113.62 -170.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.81 37.88 0.03 OUTLIER Glycine 0 N--CA 1.474 1.207 0 N-CA-C 118.776 2.271 . . . . 0.0 118.776 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.89 152.06 13.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.283 1.433 . . . . 0.0 111.519 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -76.53 172.33 13.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.584 0.754 . . . . 0.0 111.779 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -134.44 168.86 18.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.16 1.784 . . . . 0.0 110.245 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p -136.88 151.52 49.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.2 tpt -146.62 104.84 3.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.963 1.305 . . . . 0.0 108.21 166.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 -172.22 33.49 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.81 1.195 . . . . 0.0 111.991 -157.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -73.53 32.69 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.02 1.328 . . . . 0.0 111.933 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 145.76 29.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.398 2.279 . . . . 0.0 109.752 -160.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.76 -41.58 62.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -97.33 58.33 1.5 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 123.003 1.382 . . . . 0.0 111.543 -158.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -151.08 -4.49 0.3 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.626 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.1 p -70.92 -1.46 11.95 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.615 -1.303 . . . . 0.0 113.443 154.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 -170.96 33.88 Favored Glycine 0 CA--C 1.545 1.948 0 C-N-CA 127.0 2.238 . . . . 0.0 112.515 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--O 1.25 1.117 1 C-N-CA 125.956 4.438 . . . . 0.0 116.07 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.095 0.95 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.1 mtp -129.06 -30.43 2.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.729 2.012 . . . . 0.0 110.337 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.4 tp -154.2 -16.37 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 160.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.82 157.62 12.37 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 125.699 1.619 . . . . 0.0 113.444 165.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -86.08 6.99 63.53 Favored 'Cis proline' 0 CA--C 1.551 1.327 0 CA-C-N 119.801 1.8 . . . . 0.0 113.338 -11.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.89 163.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.179 2.192 . . . . 0.0 116.013 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 54.63 73.79 0.38 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.697 1.617 . . . . 0.0 115.543 167.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.36 -176.26 45.36 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 128.123 2.773 . . . . 0.0 111.773 5.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -22.26 26.89 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.596 1.158 . . . . 0.0 112.329 171.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.29 152.99 25.05 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.426 1.965 . . . . 0.0 110.558 158.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.07 43.34 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.693 1.197 . . . . 0.0 113.712 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -135.58 137.3 41.84 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.1 p -74.28 -28.34 61.15 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 -161.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -111.2 26.22 10.91 Favored 'General case' 0 N--CA 1.486 1.326 1 C-N-CA 133.984 4.913 . . . . 0.0 113.247 9.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 0.3 OUTLIER -74.97 46.16 0.29 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.802 1.641 . . . . 0.0 114.403 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.73 25.45 58.34 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.353 1.454 . . . . 0.0 114.62 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -150.93 154.34 36.97 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.759 1.224 . . . . 0.0 111.789 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.06 145.21 27.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 112.439 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -79.92 166.44 21.64 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 152.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.411 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 69' ' ' MET . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p -137.91 155.88 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -8.07 59.07 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.81 -41.83 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.017 1.77 . . . . 0.0 113.133 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -153.68 19.48 0.53 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.032 1.333 . . . . 0.0 114.303 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -153.81 156.95 38.63 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.679 2.392 . . . . 0.0 109.666 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.66 -22.85 62.44 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.54 8.4 10.12 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.479 1.912 . . . . 0.0 112.825 -161.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -43.49 -27.77 0.31 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 129.155 2.982 . . . . 0.0 113.98 168.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.8 m -142.79 53.04 1.39 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.792 1.637 . . . . 0.0 111.118 162.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.69 -173.44 22.16 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.409 1.481 . . . . 0.0 116.184 -171.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 C--N 1.358 1.032 0 N-CA-C 118.297 2.383 . . . . 0.0 118.297 6.567 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.567 0.699 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.29 167.05 23.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.259 1.824 . . . . 0.0 109.447 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.42 133.03 55.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.793 0.837 . . . . 0.0 112.23 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.81 -78.31 0.04 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 128.539 2.971 . . . . 0.0 112.928 -10.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.38 -42.14 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.465 2.11 . . . . 0.0 110.639 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -149.19 -171.66 3.94 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.73 2.012 . . . . 0.0 106.11 149.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.92 -29.81 0.32 Allowed Glycine 0 N--CA 1.474 1.209 0 O-C-N 120.586 -1.321 . . . . 0.0 114.643 171.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.28 166.27 36.16 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.723 1.154 . . . . 0.0 112.708 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 38.92 50.92 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.655 2.382 . . . . 0.0 115.282 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 32.56 0.46 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.704 2.097 . . . . 0.0 115.946 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -74.11 29.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.318 2.247 . . . . 0.0 113.137 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 49' ' ' ARG . 21.6 m-85 -142.39 118.8 10.89 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.3 p -76.64 15.79 0.59 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -160.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 47' ' ' TYR 0.268 5.7 mmm180 57.24 -10.1 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.968 3.707 . . . . 0.0 116.707 -167.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.98 -33.28 75.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.602 1.561 . . . . 0.0 112.983 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.02 31.67 0.99 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.635 1.588 . . . . 0.0 114.217 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 ttm105 -154.88 149.65 26.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.07 1.348 . . . . 0.0 111.796 -165.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -60.01 137.29 58.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 111.044 171.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t -74.49 171.24 14.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 109.523 159.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -138.18 159.67 41.44 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 tpt -147.24 144.61 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.718 1.607 . . . . 0.0 110.814 170.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.99 -82.24 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.818 1.675 . . . . 0.0 112.891 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -137.88 -3.32 1.83 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.451 1.9 . . . . 0.0 112.933 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 -146.75 154.61 41.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.122 1.369 . . . . 0.0 111.692 -149.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.45 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.72 -13.78 60.65 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -117.89 62.16 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.888 2.475 . . . . 0.0 109.645 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -144.1 109.12 4.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.53 . . . . 0.0 110.862 -153.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.7 m -147.25 69.25 1.15 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.598 3.159 . . . . 0.0 110.924 -0.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 -173.63 41.28 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 129.483 3.421 . . . . 0.0 111.432 3.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 C--O 1.251 1.149 0 CA-C-N 120.056 1.928 . . . . 0.0 113.898 -9.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 13.78 0.58 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -161.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 168.95 21.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.193 1.397 . . . . 0.0 113.049 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.47 -170.66 26.46 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.653 1.121 . . . . 0.0 113.159 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.5 145.6 11.84 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.49 3.46 . . . . 0.0 114.938 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.39 31.52 0.07 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 127.744 2.417 . . . . 0.0 114.982 -170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.62 68.13 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.555 1.55 . . . . 0.0 116.568 -171.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.11 -179.83 48.24 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.166 1.365 . . . . 0.0 112.928 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -144.84 -38.44 0.27 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.21 -172.67 13.24 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.993 1.282 . . . . 0.0 112.048 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.27 34.71 4.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.066 1.346 . . . . 0.0 111.7 -170.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 33' ' ' ASP . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 31' ' ' LEU . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.02 124.93 27.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -60.56 3.42 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.408 -165.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -150.11 -1.38 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.313 1.445 . . . . 0.0 113.425 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.19 -39.52 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.118 2.167 . . . . 0.0 112.014 -156.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.46 12.61 0.42 Allowed Glycine 0 N--CA 1.469 0.851 0 N-CA-C 118.066 1.987 . . . . 0.0 118.066 160.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -64.0 141.94 58.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.751 0.776 . . . . 0.0 110.89 157.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -71.58 123.27 22.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.64 0.776 . . . . 0.0 110.697 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -74.58 17.69 0.19 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 114.287 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -141.03 153.14 45.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -5.94 59.23 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -175.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 -36.91 0.63 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.231 1.872 . . . . 0.0 112.554 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.15 -24.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.916 1.286 . . . . 0.0 114.017 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -115.97 151.94 34.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.777 1.631 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.59 -8.67 55.45 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -116.91 -10.3 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.474 1.51 . . . . 0.0 113.573 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -54.41 -35.51 62.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.25 1.42 . . . . 0.0 113.098 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.4 p -80.47 -53.09 6.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.68 1.592 . . . . 0.0 115.088 -167.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 35.56 80.15 0.02 OUTLIER Glycine 0 CA--C 1.548 2.141 0 C-N-CA 127.647 2.546 . . . . 0.0 118.382 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.252 1.194 0 CA-C-N 120.619 2.209 . . . . 0.0 113.553 -7.303 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -140.16 149.96 43.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 112.79 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 tp -126.06 -6.4 6.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.404 2.282 . . . . 0.0 112.314 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -163.82 34.32 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.214 1.864 . . . . 0.0 110.917 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.93 30.9 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 124.278 3.318 . . . . 0.0 111.832 163.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.62 -40.79 1.73 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -151.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.85 16.71 0.07 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.447 2.927 . . . . 0.0 116.74 0.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.93 -8.0 75.04 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 120.637 2.219 . . . . 0.0 117.721 165.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.45 30.81 0.29 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.781 1.791 . . . . 0.0 113.235 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.9 -175.68 17.55 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.514 2.483 . . . . 0.0 111.131 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -119.23 36.9 4.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 110.713 165.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.46 133.1 36.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 p -74.88 24.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -161.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 76.53 3.65 3.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.926 2.89 . . . . 0.0 114.513 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.87 -35.89 1.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.78 24.14 0.02 OUTLIER Glycine 0 N--CA 1.478 1.468 0 N-CA-C 120.029 2.772 . . . . 0.0 120.029 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -153.64 152.51 30.93 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.048 1.924 . . . . 0.0 112.645 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -63.22 161.82 13.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -132.52 173.55 11.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.06 1.744 . . . . 0.0 110.864 164.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p -146.13 157.15 43.83 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.67 146.94 22.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.489 2.316 . . . . 0.0 109.731 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.82 37.45 93.68 Favored Glycine 0 CA--C 1.539 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 114.38 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 58.6 25.19 12.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.405 1.882 . . . . 0.0 114.663 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -139.54 154.33 47.64 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.491 1.916 . . . . 0.0 111.31 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.06 -17.13 64.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -127.21 -52.73 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 124.858 1.263 . . . . 0.0 110.251 -154.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.0 t60 59.85 -52.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.631 2.773 . . . . 0.0 116.677 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m -152.94 1.93 0.29 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.147 2.179 . . . . 0.0 113.783 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -122.76 1.01 Allowed Glycine 0 CA--C 1.543 1.817 0 C-N-CA 125.371 1.462 . . . . 0.0 111.188 -174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.89 2.393 . . . . 0.0 111.805 161.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.8 mtt 53.82 -54.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 130.628 3.571 . . . . 0.0 117.462 -170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.39 39.45 0.29 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.816 1.647 . . . . 0.0 111.381 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.17 154.55 25.5 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 125.859 1.695 . . . . 0.0 112.289 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -88.19 -5.39 6.64 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.177 3.251 . . . . 0.0 114.805 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -6.72 25.67 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.79 178.55 48.77 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.619 2.533 . . . . 0.0 110.454 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 166.41 34.36 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.993 1.397 . . . . 0.0 116.151 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.46 -7.65 1.14 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 115.179 -165.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.23 166.99 25.09 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 122.159 0.866 . . . . 0.0 114.597 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -107.17 80.74 1.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.192 1.397 . . . . 0.0 111.236 -160.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ILE . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.85 118.66 16.18 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -62.45 162.08 10.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.059 1.344 . . . . 0.0 111.268 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -61.98 -13.13 22.67 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -165.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 -3.13 14.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.196 1.799 . . . . 0.0 113.71 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.78 53.87 0.7 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 162.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -142.52 159.28 42.55 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.442 2.297 . . . . 0.0 110.128 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.93 154.09 42.12 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.05 -1.031 . . . . 0.0 112.641 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -110.88 -4.71 15.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p -144.89 154.83 43.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.4 tpt -148.1 151.28 35.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.81 2.044 . . . . 0.0 108.73 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 54.83 37.44 62.01 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 114.946 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 58.93 26.73 15.33 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.089 1.756 . . . . 0.0 114.202 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 -141.57 156.74 45.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.7 2.0 . . . . 0.0 110.775 -173.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.39 -40.76 57.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -80.68 -48.05 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.177 0.898 . . . . 0.0 111.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.311 39.8 t60 49.71 26.76 1.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 128.267 2.627 . . . . 0.0 115.867 161.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 p 164.01 66.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.473 3.109 . . . . 0.0 110.636 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.25 -179.33 35.52 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.685 2.564 . . . . 0.0 115.453 11.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.285 3.99 . . . . 0.0 114.866 167.037 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.3 tpt -80.63 26.76 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.582 1.553 . . . . 0.0 114.591 -163.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.53 -32.92 59.13 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -161.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.87 174.28 22.46 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 125.01 1.291 . . . . 0.0 113.465 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.11 172.41 61.92 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 118.663 1.231 . . . . 0.0 114.163 3.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -72.89 151.77 41.77 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.656 1.183 . . . . 0.0 111.497 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.76 -164.65 13.43 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 127.082 2.277 . . . . 0.0 113.045 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.2 14.62 0.1 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.61 53.91 0.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.807 2.043 . . . . 0.0 112.494 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.17 -163.48 47.11 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.94 -158.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -122.69 41.01 3.55 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.215 1.406 . . . . 0.0 110.039 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -147.84 100.28 3.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.75 95.43 0.24 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 109.828 -176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? 27.55 59.19 0.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.464 2.706 . . . . 0.0 115.048 -163.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 66.71 -3.54 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.375 2.27 . . . . 0.0 115.692 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.66 -31.72 48.84 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.537 1.065 . . . . 0.0 114.148 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -162.51 153.14 17.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.618 1.567 . . . . 0.0 110.828 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -59.2 135.74 57.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.155 158.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p -87.42 6.18 35.16 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -123.81 156.22 36.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 14.9 tpt -146.33 146.45 30.69 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.075 1.35 . . . . 0.0 110.559 163.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.96 -81.83 0.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.379 1.466 . . . . 0.0 112.442 -171.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -156.55 19.66 0.34 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.152 1.781 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.82 156.27 41.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.373 1.869 . . . . 0.0 110.157 -156.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.61 -15.71 63.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.28 -52.64 2.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 126.318 1.847 . . . . 0.0 110.175 -174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.261 77.6 t60 40.66 45.93 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.677 3.191 . . . . 0.0 114.692 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -157.94 -2.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.802 1.641 . . . . 0.0 115.222 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 167.22 53.91 0.03 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--O 1.248 0.985 0 CA-C-N 122.441 3.121 . . . . 0.0 109.985 -14.367 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.4 -57.63 7.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -157.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.34 -30.54 22.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.093 2.957 . . . . 0.0 112.645 -14.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.93 -53.71 0.42 Allowed Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.496 1.522 . . . . 0.0 113.72 164.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.89 -22.04 22.71 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.678 3.585 . . . . 0.0 116.125 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.37 1.45 2.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.434 1.494 . . . . 0.0 114.525 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.91 -25.93 0.03 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.94 -45.71 1.98 Allowed Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 165.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.49 -26.26 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.79 159.87 24.63 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 122.156 0.865 . . . . 0.0 114.818 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -85.11 32.55 0.54 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.025 1.73 . . . . 0.0 113.843 -167.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.494 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 19' ' ' PRO . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 78' ' ' MET . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 40' ' ' ALA . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -138.52 138.72 38.3 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -117.4 33.49 5.6 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -122.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER 41.52 40.93 1.46 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.01 1.724 . . . . 0.0 113.96 -168.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -153.64 -18.68 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.64 1.576 . . . . 0.0 114.524 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.05 40.34 7.08 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.375 0.989 . . . . 0.0 112.672 -171.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -153.15 144.96 23.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.317 1.847 . . . . 0.0 109.428 -170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -81.26 144.9 31.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.093 0.949 . . . . 0.0 111.381 160.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p -84.94 -12.12 54.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -162.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -143.77 152.4 41.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.434 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 2.7 tpt -151.93 147.14 26.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.198 1.799 . . . . 0.0 110.982 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.96 33.23 82.99 Favored Glycine 0 CA--C 1.541 1.681 0 O-C-N 121.61 -0.681 . . . . 0.0 113.455 -167.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 56.54 32.06 20.15 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 114.112 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -147.28 153.72 40.09 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.87 -14.64 62.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -39.59 28.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.563 1.145 . . . . 0.0 110.561 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -71.39 45.79 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 129.06 2.944 . . . . 0.0 112.926 169.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 m -152.22 178.82 9.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.455 1.502 . . . . 0.0 112.62 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.81 -155.36 7.25 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.703 1.62 . . . . 0.0 111.95 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.693 2.929 . . . . 0.0 112.273 167.223 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 tpt 60.45 -48.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.71 2.404 . . . . 0.0 115.277 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.3 tp -150.09 -16.4 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 114.888 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.45 29.65 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.356 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -87.53 -15.98 26.66 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 120.092 1.946 . . . . 0.0 113.943 -1.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -27.87 69.13 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.93 -2.62 0.21 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.612 -1.66 . . . . 0.0 117.223 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.99 -173.85 25.94 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 120.995 2.398 . . . . 0.0 116.565 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -45.0 8.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.236 174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.45 -154.35 24.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.823 0.725 . . . . 0.0 113.059 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -124.09 38.72 4.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.606 1.962 . . . . 0.0 110.441 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 36' ' ' ILE . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' H ' HG21 ' A' ' 46' ' ' ILE . 39.2 m-85 -160.24 138.86 10.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.3 p -110.48 14.27 22.56 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -160.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -116.92 -149.7 0.45 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 116.555 -3.841 . . . . 0.0 113.233 38.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 0.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -156.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -109.93 1.08 30.15 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.668 1.604 . . . . 0.0 115.272 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -146.48 77.77 1.49 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.652 1.226 . . . . 0.0 112.387 -160.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -52.53 124.51 13.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.454 1.501 . . . . 0.0 112.745 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p -82.4 -5.23 58.51 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 64' ' ' GLU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 164.96 14.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -14.87 11.86 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.45 -0.781 . . . . 0.0 112.803 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.58 112.97 0.43 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.339 1.924 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.7 m80 59.8 -7.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.356 2.262 . . . . 0.0 117.093 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -151.39 155.38 38.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.288 1.835 . . . . 0.0 112.15 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.05 -10.3 59.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -145.38 60.13 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 110.44 -151.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.48 -6.42 4.2 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -140.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.6 t -161.06 -18.06 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.0 66.58 0.01 OUTLIER Glycine 0 CA--C 1.541 1.685 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.575 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 C--O 1.247 0.937 0 CA-C-N 120.815 2.307 . . . . 0.0 111.103 2.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.7 mtp -137.63 -11.3 1.59 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.9 -7.18 5.54 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 -163.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.86 -79.5 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.909 -0.939 . . . . 0.0 113.981 158.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 -21.1 30.12 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.184 2.59 . . . . 0.0 111.06 161.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -76.75 75.34 3.4 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 148.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -0.13 105.56 0.01 OUTLIER Glycine 0 N--CA 1.478 1.494 1 C-N-CA 131.231 4.253 . . . . 0.0 118.366 -169.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.7 1.19 21.7 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.209 1.385 . . . . 0.0 116.155 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 -20.81 4.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.186 1.493 . . . . 0.0 113.924 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.02 -168.68 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.46 1.505 . . . . 0.0 112.052 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -123.46 36.33 4.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 112.476 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.8 110.27 7.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -66.84 178.98 1.18 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.134 0.974 . . . . 0.0 111.909 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -24.25 54.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.841 0.857 . . . . 0.0 113.156 169.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.35 -10.39 59.54 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.388 1.075 . . . . 0.0 113.538 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.58 41.69 28.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.216 -0.927 . . . . 0.0 112.542 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -150.96 149.02 29.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.802 1.641 . . . . 0.0 110.999 -160.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -66.95 123.46 20.27 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.079 -1.013 . . . . 0.0 113.434 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -74.16 11.28 0.96 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.086 1.754 . . . . 0.0 115.089 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p -128.31 153.43 47.0 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.43 115.45 5.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.867 1.667 . . . . 0.0 107.767 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.6 -168.59 53.8 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.776 0.703 . . . . 0.0 112.198 -157.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -72.47 30.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.583 1.553 . . . . 0.0 113.038 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -148.67 147.3 28.76 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.41 2.284 . . . . 0.0 110.737 -155.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.95 -18.45 64.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -145.05 48.24 1.3 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 123.824 1.773 . . . . 0.0 108.731 -141.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -81.65 13.93 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.733 -136.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.1 p -142.88 11.23 1.81 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.303 2.241 . . . . 0.0 113.808 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.69 169.34 32.34 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 116.177 1.231 . . . . 0.0 116.177 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.252 1.198 1 C-N-CA 125.37 4.047 . . . . 0.0 114.085 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt 138.94 -18.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 1 C-N-CA 132.188 4.195 . . . . 0.0 110.639 -164.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.12 172.71 12.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.318 1.847 . . . . 0.0 113.173 -160.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.74 -33.41 1.58 Allowed Glycine 0 CA--C 1.547 2.045 0 N-CA-C 119.311 2.485 . . . . 0.0 119.311 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.37 -11.69 3.26 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.144 3.229 . . . . 0.0 117.055 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.01 161.25 32.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.683 1.593 . . . . 0.0 112.209 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.01 109.42 0.8 Allowed Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.882 1.23 . . . . 0.0 113.355 -170.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.07 39.15 1.47 Allowed Glycine 0 CA--C 1.532 1.109 0 O-C-N 119.11 -2.406 . . . . 0.0 113.446 -21.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -128.96 3.66 5.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.614 2.366 . . . . 0.0 114.631 23.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.53 60.6 0.1 Allowed Glycine 0 N--CA 1.47 0.945 0 O-C-N 121.066 -1.021 . . . . 0.0 114.63 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.27 45.75 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.744 2.018 . . . . 0.0 114.625 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -137.94 146.01 42.72 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -125.87 46.88 2.32 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -160.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -0.06 2.77 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.276 -3.39 . . . . 0.0 113.922 16.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.76 -28.97 2.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -153.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.74 28.16 0.25 Allowed Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.683 1.135 . . . . 0.0 113.948 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -158.91 120.15 3.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.076 1.35 . . . . 0.0 111.011 -162.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -61.31 165.38 4.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.261 172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -134.57 168.91 18.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.403 1.481 . . . . 0.0 110.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -145.89 160.32 41.97 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 tpt -150.0 84.09 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.357 1.063 . . . . 0.0 112.422 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.29 1.38 7.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.697 3.046 . . . . 0.0 113.385 -5.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -126.14 4.9 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.654 1.982 . . . . 0.0 111.676 171.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.81 149.57 38.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.444 2.697 . . . . 0.0 109.985 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.12 -3.86 41.51 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -120.49 8.27 10.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.831 2.452 . . . . 0.0 111.649 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -57.95 -18.17 21.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 129.401 3.08 . . . . 0.0 114.585 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -58.43 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.039 1.736 . . . . 0.0 112.438 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.11 63.68 0.06 OUTLIER Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.348 1.452 . . . . 0.0 114.177 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.249 1.073 0 CA-C-N 120.222 2.011 . . . . 0.0 113.396 1.559 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.0 mmt -59.57 -26.77 65.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.689 1.196 . . . . 0.0 112.545 169.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -131.58 160.98 33.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.825 2.05 . . . . 0.0 111.44 159.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 20.49 67.07 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 128.353 2.882 . . . . 0.0 118.641 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.63 151.14 86.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.718 2.946 . . . . 0.0 113.79 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.64 -34.4 0.92 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.72 -43.75 0.03 OUTLIER Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.912 1.233 . . . . 0.0 115.036 -176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.37 -18.9 0.27 Allowed Glycine 0 CA--C 1.544 1.885 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -61.45 -24.51 66.6 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.579 2.19 . . . . 0.0 113.784 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.45 178.77 38.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.756 2.122 . . . . 0.0 109.148 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -117.25 31.55 6.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.229 1.412 . . . . 0.0 110.39 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' CG1' ' A' ' 27' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 33' ' ' ASP . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HG ' ' HB2' ' A' ' 69' ' ' MET . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -138.46 151.81 47.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.81 -21.24 48.01 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -150.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -111.7 152.69 27.44 Favored 'General case' 0 N--CA 1.48 1.04 2 C-N-CA 132.367 4.267 . . . . 0.0 110.017 -17.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -81.28 -177.61 6.55 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.888 2.475 . . . . 0.0 110.154 -21.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.7 -58.1 0.57 Allowed Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.117 0.865 . . . . 0.0 113.935 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -155.52 169.14 24.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.291 1.437 . . . . 0.0 111.03 -170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -66.89 166.43 13.45 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.51 0.671 . . . . 0.0 111.606 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t -123.68 176.64 6.12 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.905 1.682 . . . . 0.0 109.406 167.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.463 ' HB2' ' HG ' ' A' ' 34' ' ' CYS . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p -127.54 152.15 47.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.1 tpt -151.5 153.54 34.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.199 1.399 . . . . 0.0 111.046 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.09 -79.69 0.39 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.848 1.213 . . . . 0.0 111.123 -166.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -156.34 15.11 0.32 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.736 1.615 . . . . 0.0 112.894 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -140.01 156.91 46.4 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.835 2.054 . . . . 0.0 111.819 -158.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.45 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.67 -11.24 59.92 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -98.56 -18.81 17.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.376 1.47 . . . . 0.0 113.034 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -53.8 135.7 41.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.84 2.056 . . . . 0.0 114.028 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.49 -34.66 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.969 1.308 . . . . 0.0 112.348 162.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.85 80.42 0.03 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.853 2.168 . . . . 0.0 111.829 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.253 1.23 0 CA-C-N 120.925 2.362 . . . . 0.0 116.469 0.823 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.5 mmt 59.77 24.4 13.35 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.708 2.003 . . . . 0.0 116.323 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -149.01 173.13 13.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.896 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 174.47 12.85 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.598 1.57 . . . . 0.0 115.401 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.84 -4.23 58.02 Favored 'Cis proline' 0 CA--C 1.546 1.079 0 CA-C-N 118.553 1.177 . . . . 0.0 114.651 3.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -61.76 -43.73 98.29 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 -2.35 0.19 Allowed Glycine 0 CA--C 1.541 1.7 0 C-N-CA 130.131 3.729 . . . . 0.0 114.547 -14.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.79 20.96 0.9 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 118.924 1.362 . . . . 0.0 115.181 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 -34.17 0.22 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.484 1.914 . . . . 0.0 113.145 -169.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.13 140.23 3.56 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.477 1.037 . . . . 0.0 112.478 163.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -75.69 56.51 0.92 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 112.787 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -102.05 -159.85 0.75 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 p -135.54 172.81 12.47 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 120.461 -1.399 . . . . 0.0 110.238 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -53.65 -1.9 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 159.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.84 -0.34 9.61 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.598 2.359 . . . . 0.0 113.404 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.71 35.34 28.77 Favored Glycine 0 N--CA 1.476 1.347 0 O-C-N 120.94 -1.1 . . . . 0.0 115.179 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -147.49 135.97 21.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.425 1.49 . . . . 0.0 111.409 -161.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -60.13 144.7 49.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.139 0.881 . . . . 0.0 112.538 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -111.78 7.17 20.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.8 1.24 . . . . 0.0 113.249 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.439 ' CG1' ' HE2' ' A' ' 87' ' ' LYS . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p -141.04 149.32 41.54 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 tpp -157.55 81.18 0.89 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.462 1.505 . . . . 0.0 110.624 168.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.66 -41.25 0.06 OUTLIER Glycine 0 N--CA 1.477 1.432 0 C-N-CA 127.893 2.663 . . . . 0.0 113.627 4.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -74.73 12.28 0.86 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.807 1.243 . . . . 0.0 112.662 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -154.54 158.44 39.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.512 2.725 . . . . 0.0 110.86 -161.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.36 -30.0 37.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -76.05 -23.39 55.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.504 1.922 . . . . 0.0 112.841 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -39.52 -28.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.907 2.083 . . . . 0.0 114.692 153.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.1 p -129.92 13.73 5.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 114.641 -173.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.13 -172.32 39.95 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--O 1.255 1.351 1 C-N-CA 125.36 4.04 . . . . 0.0 115.058 171.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.8 mmm 56.33 34.45 24.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.221 1.808 . . . . 0.0 114.315 -175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.4 mt -122.25 -7.54 8.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.689 1.995 . . . . 0.0 113.77 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.69 -158.91 32.0 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.775 0.702 . . . . 0.0 114.259 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.93 112.68 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.977 2.451 . . . . 0.0 109.665 164.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -152.28 128.79 10.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.013 1.325 . . . . 0.0 111.296 -165.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.84 178.11 41.23 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 128.255 2.836 . . . . 0.0 109.998 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.45 -36.06 1.59 Allowed Glycine 0 N--CA 1.477 1.383 0 CA-C-N 118.231 1.015 . . . . 0.0 114.986 170.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -20.24 63.13 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.372 1.086 . . . . 0.0 111.879 157.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.43 -170.57 39.2 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.983 2.23 . . . . 0.0 111.411 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.99 42.08 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.377 2.271 . . . . 0.0 110.0 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -121.59 103.94 9.27 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -54.29 -49.7 69.01 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -148.9 -38.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -123.95 -32.57 3.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -166.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.15 44.74 0.02 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -149.62 152.1 34.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.527 1.131 . . . . 0.0 112.153 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -61.84 136.3 57.93 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -166.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t -93.27 178.61 5.67 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.146 0.978 . . . . 0.0 109.55 146.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p -132.22 157.59 43.95 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ptm -79.87 8.11 7.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.537 1.135 . . . . 0.0 113.555 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.32 -8.53 44.7 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.612 2.053 . . . . 0.0 113.871 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -151.14 -31.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.35 157.85 45.31 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.504 1.922 . . . . 0.0 111.648 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.66 -13.95 62.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -110.69 -46.87 3.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.608 1.563 . . . . 0.0 111.516 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.258 1.6 t60 55.1 -36.06 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.867 3.667 . . . . 0.0 118.981 164.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -73.52 -7.85 53.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.793 1.633 . . . . 0.0 112.975 165.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.13 -176.99 46.53 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.793 1.663 . . . . 0.0 113.56 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 C-N-CA 124.898 3.732 . . . . 0.0 112.956 170.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 13.6 tpt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt -53.74 -18.98 3.59 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.72 -10.59 28.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.933 1.693 . . . . 0.0 115.106 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.5 -109.03 0.26 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.421 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.52 -178.47 3.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.367 3.378 . . . . 0.0 113.247 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 1' ' ' MET . 78.3 mm-40 -116.34 78.33 1.19 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.609 1.564 . . . . 0.0 110.21 163.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.19 64.69 0.66 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.652 2.549 . . . . 0.0 113.996 1.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 -48.04 8.02 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 118.048 1.979 . . . . 0.0 118.048 169.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.26 109.34 13.27 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 131.756 4.023 . . . . 0.0 110.801 6.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.66 -7.02 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.723 1.154 . . . . 0.0 115.807 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.76 29.62 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.304 1.552 . . . . 0.0 113.327 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.45 119.5 16.49 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.5 p -64.6 166.09 9.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.564 0.746 . . . . 0.0 110.815 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -66.68 -4.4 8.77 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.03 -5.43 10.53 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.744 1.618 . . . . 0.0 114.805 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 58.88 0.49 Allowed Glycine 0 N--CA 1.475 1.253 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 164.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.8 ttm105 -148.4 147.64 29.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.82 1.648 . . . . 0.0 111.058 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -57.27 126.9 29.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.201 0.909 . . . . 0.0 111.044 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -81.73 9.52 7.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.334 1.453 . . . . 0.0 114.202 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HA ' HG11 ' A' ' 67' ' ' VAL . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -137.86 147.96 44.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 tpp -151.85 131.98 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.187 1.395 . . . . 0.0 109.921 163.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.41 -163.12 52.73 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.72 0.676 . . . . 0.0 112.249 -160.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -70.51 28.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.223 1.809 . . . . 0.0 113.454 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -153.08 163.86 39.07 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.801 1.64 . . . . 0.0 112.639 -140.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.501 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.09 -37.55 61.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.03 -47.63 43.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.884 1.274 . . . . 0.0 111.633 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 28.25 62.22 0.12 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.84 2.456 . . . . 0.0 114.879 159.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.5 t -129.72 147.55 51.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.239 2.616 . . . . 0.0 111.723 1.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.97 175.87 46.97 Favored Glycine 0 CA--C 1.544 1.868 0 C-N-CA 125.416 1.484 . . . . 0.0 113.643 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.829 3.686 . . . . 0.0 113.008 -177.474 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HB3' HD21 ' A' ' 18' ' ' LEU . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 43' ' ' VAL . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 67' ' ' VAL . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.563 ' HB3' HD22 ' A' ' 61' ' ' LEU . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 96' ' ' VAL . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 58' ' ' PHE . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.662 HG13 HG21 ' A' ' 43' ' ' VAL . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.662 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.418 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 96' ' ' VAL . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 96' ' ' VAL . 10.7 mp . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 24' ' ' VAL . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.477 ' HB3' HD21 ' A' ' 97' ' ' LEU . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.804 0.335 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.536 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 96' ' ' VAL . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.2 mp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.052 0.93 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.6 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG2' HG22 ' A' ' 24' ' ' VAL . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.453 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 . . . . . 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' HG13 ' A' ' 67' ' ' VAL . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.988 0.899 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.453 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.1 mp . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 HD11 ' A' ' 61' ' ' LEU . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 HG11 ' A' ' 43' ' ' VAL . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 24' ' ' VAL . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.652 0.263 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 43' ' ' VAL . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.662 ' HA ' HG13 ' A' ' 67' ' ' VAL . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.696 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 58' ' ' PHE . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 43' ' ' VAL . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 24' ' ' VAL . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.495 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.206 0.527 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 44' ' ' HIS . 9.3 mp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 122.275 1.036 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 83' ' ' ILE . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.681 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.459 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.517 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 96' ' ' VAL . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 27' ' ' VAL . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 73' ' ' LYS . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 24' ' ' VAL . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.699 ' CE1' HG21 ' A' ' 96' ' ' VAL . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 43' ' ' VAL . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 67' ' ' VAL . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 96' ' ' VAL . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.699 HG21 ' CE1' ' A' ' 58' ' ' PHE . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.932 0.872 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HB3' HD21 ' A' ' 18' ' ' LEU . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 15' ' ' LEU . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.752 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 83' ' ' ILE . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.752 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 46' ' ' ILE . 39.2 m-85 . . . . . 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 67' ' ' VAL . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB3' HD22 ' A' ' 61' ' ' LEU . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.756 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 121.234 0.54 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 96' ' ' VAL . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.616 0.722 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 43' ' ' VAL . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 83' ' ' ILE . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.42 ' CB ' HD21 ' A' ' 97' ' ' LEU . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 64' ' ' GLU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 44' ' ' HIS . 8.0 mp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG13 HG21 ' A' ' 43' ' ' VAL . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 24' ' ' VAL . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 31' ' ' LEU . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 30' ' ' PHE . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 36' ' ' ILE . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.465 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.947 0.404 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 27' ' ' VAL . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 67' ' ' VAL . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.664 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.301 0.572 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 96' ' ' VAL . 11.0 mp . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 121.602 0.715 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.673 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 83' ' ' ILE . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.673 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 97' ' ' LEU . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 ' HB ' ' A' ' 43' ' ' VAL . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.606 ' HA ' HG13 ' A' ' 67' ' ' VAL . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.451 HG21 ' CE2' ' A' ' 30' ' ' PHE . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.432 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.445 ' HB3' HG23 ' A' ' 67' ' ' VAL . 37.5 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.715 0.769 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.443 HG22 HD11 ' A' ' 61' ' ' LEU . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 27' ' ' VAL . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 24' ' ' VAL . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 59' ' ' VAL . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.547 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 97' ' ' LEU . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 . . . . . 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 43' ' ' VAL . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HA ' HD13 ' A' ' 61' ' ' LEU . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 93' ' ' MET . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 44' ' ' HIS . 10.1 mp . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.882 0.849 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.657 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 67' ' ' VAL . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.657 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.3 mp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.628 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.473 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.0 mp . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 122.506 1.146 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 ttp -155.68 -32.67 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.264 3.026 . . . . 0.0 110.298 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.56 153.95 51.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.197 2.599 . . . . 0.0 109.615 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.54 -162.11 33.16 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.019 0.768 . . . . 0.0 115.019 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.17 -29.04 1.83 Allowed 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 118.361 1.081 . . . . 0.0 114.663 -2.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.27 169.73 6.25 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.96 2.904 . . . . 0.0 108.748 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.72 49.26 0.22 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 37.53 0.34 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.673 1.606 . . . . 0.0 115.811 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.7 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 1 C-N-CA 133.998 4.919 . . . . 0.0 120.408 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.66 4.61 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.956 1.265 . . . . 0.0 114.676 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -81.94 27.41 0.47 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.956 1.378 . . . . 0.0 113.801 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HB3' HD21 ' A' ' 18' ' ' LEU . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -140.22 133.97 30.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -67.87 -10.24 51.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.271 87.0 mtt-85 118.29 -0.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 131.9 4.08 . . . . 0.0 112.771 150.115 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.75 -25.51 1.65 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.112 1.765 . . . . 0.0 113.62 -170.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.81 37.88 0.03 OUTLIER Glycine 0 N--CA 1.474 1.207 0 N-CA-C 118.776 2.271 . . . . 0.0 118.776 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.89 152.06 13.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.283 1.433 . . . . 0.0 111.519 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -76.53 172.33 13.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.584 0.754 . . . . 0.0 111.779 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -134.44 168.86 18.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.16 1.784 . . . . 0.0 110.245 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 43' ' ' VAL . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 67' ' ' VAL . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.563 ' HB3' HD22 ' A' ' 61' ' ' LEU . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p -136.88 151.52 49.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.2 tpt -146.62 104.84 3.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.963 1.305 . . . . 0.0 108.21 166.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 -172.22 33.49 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.81 1.195 . . . . 0.0 111.991 -157.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -73.53 32.69 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.02 1.328 . . . . 0.0 111.933 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 145.76 29.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.398 2.279 . . . . 0.0 109.752 -160.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 96' ' ' VAL . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 58' ' ' PHE . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp -73.76 -41.58 62.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -97.33 58.33 1.5 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 123.003 1.382 . . . . 0.0 111.543 -158.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -151.08 -4.49 0.3 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.626 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.1 p -70.92 -1.46 11.95 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.615 -1.303 . . . . 0.0 113.443 154.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 -170.96 33.88 Favored Glycine 0 CA--C 1.545 1.948 0 C-N-CA 127.0 2.238 . . . . 0.0 112.515 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--O 1.25 1.117 1 C-N-CA 125.956 4.438 . . . . 0.0 116.07 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.095 0.95 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.1 mtp -129.06 -30.43 2.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.729 2.012 . . . . 0.0 110.337 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.4 tp -154.2 -16.37 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 160.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.82 157.62 12.37 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 125.699 1.619 . . . . 0.0 113.444 165.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -86.08 6.99 63.53 Favored 'Cis proline' 0 CA--C 1.551 1.327 0 CA-C-N 119.801 1.8 . . . . 0.0 113.338 -11.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.89 163.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.179 2.192 . . . . 0.0 116.013 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 54.63 73.79 0.38 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.697 1.617 . . . . 0.0 115.543 167.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.36 -176.26 45.36 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 128.123 2.773 . . . . 0.0 111.773 5.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -22.26 26.89 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.596 1.158 . . . . 0.0 112.329 171.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.29 152.99 25.05 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.426 1.965 . . . . 0.0 110.558 158.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.07 43.34 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.693 1.197 . . . . 0.0 113.712 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.662 HG13 HG21 ' A' ' 43' ' ' VAL . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.662 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.418 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -135.58 137.3 41.84 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.402 ' N ' ' HA ' ' A' ' 49' ' ' ARG . 41.1 p -74.28 -28.34 61.15 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 -161.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HA ' ' N ' ' A' ' 48' ' ' THR . 1.1 mtt-85 -111.2 26.22 10.91 Favored 'General case' 0 N--CA 1.486 1.326 1 C-N-CA 133.984 4.913 . . . . 0.0 113.247 9.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 50' ' ' GLU 0.315 0.3 OUTLIER -74.97 46.16 0.29 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.802 1.641 . . . . 0.0 114.403 179.444 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.73 25.45 58.34 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.353 1.454 . . . . 0.0 114.62 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -150.93 154.34 36.97 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.759 1.224 . . . . 0.0 111.789 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.06 145.21 27.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 112.439 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -79.92 166.44 21.64 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 152.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p -137.91 155.88 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -8.07 59.07 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.81 -41.83 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.017 1.77 . . . . 0.0 113.133 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -153.68 19.48 0.53 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.032 1.333 . . . . 0.0 114.303 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -153.81 156.95 38.63 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.679 2.392 . . . . 0.0 109.666 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 96' ' ' VAL . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 96' ' ' VAL . 10.7 mp -70.66 -22.85 62.44 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.54 8.4 10.12 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.479 1.912 . . . . 0.0 112.825 -161.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -43.49 -27.77 0.31 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 129.155 2.982 . . . . 0.0 113.98 168.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.8 m -142.79 53.04 1.39 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.792 1.637 . . . . 0.0 111.118 162.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.69 -173.44 22.16 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.409 1.481 . . . . 0.0 116.184 -171.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 C--N 1.358 1.032 0 N-CA-C 118.297 2.383 . . . . 0.0 118.297 6.567 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.567 0.699 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.29 167.05 23.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.259 1.824 . . . . 0.0 109.447 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.42 133.03 55.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.793 0.837 . . . . 0.0 112.23 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.81 -78.31 0.04 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 128.539 2.971 . . . . 0.0 112.928 -10.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.38 -42.14 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.465 2.11 . . . . 0.0 110.639 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -149.19 -171.66 3.94 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.73 2.012 . . . . 0.0 106.11 149.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.92 -29.81 0.32 Allowed Glycine 0 N--CA 1.474 1.209 0 O-C-N 120.586 -1.321 . . . . 0.0 114.643 171.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.28 166.27 36.16 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.723 1.154 . . . . 0.0 112.708 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 38.92 50.92 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.655 2.382 . . . . 0.0 115.282 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 32.56 0.46 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.704 2.097 . . . . 0.0 115.946 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -74.11 29.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.318 2.247 . . . . 0.0 113.137 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 24' ' ' VAL . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.477 ' HB3' HD21 ' A' ' 97' ' ' LEU . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -142.39 118.8 10.89 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.3 p -76.64 15.79 0.59 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -160.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.268 5.7 mmm180 57.24 -10.1 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.968 3.707 . . . . 0.0 116.707 -167.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.98 -33.28 75.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.602 1.561 . . . . 0.0 112.983 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.02 31.67 0.99 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.635 1.588 . . . . 0.0 114.217 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 ttm105 -154.88 149.65 26.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.07 1.348 . . . . 0.0 111.796 -165.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -60.01 137.29 58.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 111.044 171.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t -74.49 171.24 14.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 109.523 159.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -138.18 159.67 41.44 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 tpt -147.24 144.61 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.718 1.607 . . . . 0.0 110.814 170.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.99 -82.24 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.818 1.675 . . . . 0.0 112.891 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -137.88 -3.32 1.83 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.451 1.9 . . . . 0.0 112.933 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 -146.75 154.61 41.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.122 1.369 . . . . 0.0 111.692 -149.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.536 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 96' ' ' VAL . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.2 mp -74.72 -13.78 60.65 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -117.89 62.16 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.888 2.475 . . . . 0.0 109.645 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -144.1 109.12 4.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.53 . . . . 0.0 110.862 -153.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.7 m -147.25 69.25 1.15 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.598 3.159 . . . . 0.0 110.924 -0.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 -173.63 41.28 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 129.483 3.421 . . . . 0.0 111.432 3.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 C--O 1.251 1.149 0 CA-C-N 120.056 1.928 . . . . 0.0 113.898 -9.573 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 13.78 0.58 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -161.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 168.95 21.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.193 1.397 . . . . 0.0 113.049 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.47 -170.66 26.46 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.653 1.121 . . . . 0.0 113.159 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.5 145.6 11.84 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.49 3.46 . . . . 0.0 114.938 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.39 31.52 0.07 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 127.744 2.417 . . . . 0.0 114.982 -170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.62 68.13 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.555 1.55 . . . . 0.0 116.568 -171.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.11 -179.83 48.24 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.166 1.365 . . . . 0.0 112.928 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -144.84 -38.44 0.27 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.21 -172.67 13.24 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.993 1.282 . . . . 0.0 112.048 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.27 34.71 4.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.066 1.346 . . . . 0.0 111.7 -170.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.6 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG2' HG22 ' A' ' 24' ' ' VAL . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.453 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.02 124.93 27.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -60.56 3.42 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.408 -165.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -150.11 -1.38 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.313 1.445 . . . . 0.0 113.425 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.19 -39.52 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.118 2.167 . . . . 0.0 112.014 -156.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.46 12.61 0.42 Allowed Glycine 0 N--CA 1.469 0.851 0 N-CA-C 118.066 1.987 . . . . 0.0 118.066 160.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -64.0 141.94 58.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.751 0.776 . . . . 0.0 110.89 157.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -71.58 123.27 22.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.64 0.776 . . . . 0.0 110.697 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -74.58 17.69 0.19 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 114.287 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' HG13 ' A' ' 67' ' ' VAL . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -141.03 153.14 45.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -5.94 59.23 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 -36.91 0.63 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.231 1.872 . . . . 0.0 112.554 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.15 -24.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.916 1.286 . . . . 0.0 114.017 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -115.97 151.94 34.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.777 1.631 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.453 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.1 mp -71.59 -8.67 55.45 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -116.91 -10.3 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.474 1.51 . . . . 0.0 113.573 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -54.41 -35.51 62.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.25 1.42 . . . . 0.0 113.098 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.4 p -80.47 -53.09 6.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.68 1.592 . . . . 0.0 115.088 -167.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 35.56 80.15 0.02 OUTLIER Glycine 0 CA--C 1.548 2.141 0 C-N-CA 127.647 2.546 . . . . 0.0 118.382 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.252 1.194 0 CA-C-N 120.619 2.209 . . . . 0.0 113.553 -7.303 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -140.16 149.96 43.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 112.79 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 tp -126.06 -6.4 6.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.404 2.282 . . . . 0.0 112.314 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -163.82 34.32 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.214 1.864 . . . . 0.0 110.917 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.93 30.9 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 124.278 3.318 . . . . 0.0 111.832 163.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.62 -40.79 1.73 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -151.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.85 16.71 0.07 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.447 2.927 . . . . 0.0 116.74 0.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.93 -8.0 75.04 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 120.637 2.219 . . . . 0.0 117.721 165.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.45 30.81 0.29 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.781 1.791 . . . . 0.0 113.235 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.9 -175.68 17.55 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.514 2.483 . . . . 0.0 111.131 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -119.23 36.9 4.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 110.713 165.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 HD11 ' A' ' 61' ' ' LEU . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 HG11 ' A' ' 43' ' ' VAL . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 24' ' ' VAL . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.46 133.1 36.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 p -74.88 24.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -161.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 76.53 3.65 3.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.926 2.89 . . . . 0.0 114.513 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.87 -35.89 1.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.78 24.14 0.02 OUTLIER Glycine 0 N--CA 1.478 1.468 0 N-CA-C 120.029 2.772 . . . . 0.0 120.029 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -153.64 152.51 30.93 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.048 1.924 . . . . 0.0 112.645 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -63.22 161.82 13.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -132.52 173.55 11.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.06 1.744 . . . . 0.0 110.864 164.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 43' ' ' VAL . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.662 ' HA ' HG13 ' A' ' 67' ' ' VAL . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.696 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p -146.13 157.15 43.83 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.67 146.94 22.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.489 2.316 . . . . 0.0 109.731 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.82 37.45 93.68 Favored Glycine 0 CA--C 1.539 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 114.38 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 58.6 25.19 12.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.405 1.882 . . . . 0.0 114.663 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -139.54 154.33 47.64 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.491 1.916 . . . . 0.0 111.31 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 58' ' ' PHE . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp -66.06 -17.13 64.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -127.21 -52.73 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 124.858 1.263 . . . . 0.0 110.251 -154.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.0 t60 59.85 -52.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.631 2.773 . . . . 0.0 116.677 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m -152.94 1.93 0.29 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.147 2.179 . . . . 0.0 113.783 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -122.76 1.01 Allowed Glycine 0 CA--C 1.543 1.817 0 C-N-CA 125.371 1.462 . . . . 0.0 111.188 -174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.89 2.393 . . . . 0.0 111.805 161.611 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.8 mtt 53.82 -54.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 130.628 3.571 . . . . 0.0 117.462 -170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.39 39.45 0.29 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.816 1.647 . . . . 0.0 111.381 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.17 154.55 25.5 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 125.859 1.695 . . . . 0.0 112.289 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -88.19 -5.39 6.64 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.177 3.251 . . . . 0.0 114.805 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -6.72 25.67 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.79 178.55 48.77 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.619 2.533 . . . . 0.0 110.454 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 166.41 34.36 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.993 1.397 . . . . 0.0 116.151 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.46 -7.65 1.14 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 115.179 -165.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.23 166.99 25.09 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 122.159 0.866 . . . . 0.0 114.597 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -107.17 80.74 1.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.192 1.397 . . . . 0.0 111.236 -160.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 43' ' ' VAL . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 24' ' ' VAL . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.495 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.85 118.66 16.18 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -62.45 162.08 10.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.059 1.344 . . . . 0.0 111.268 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -61.98 -13.13 22.67 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -165.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 -3.13 14.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.196 1.799 . . . . 0.0 113.71 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.78 53.87 0.7 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 162.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -142.52 159.28 42.55 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.442 2.297 . . . . 0.0 110.128 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.93 154.09 42.12 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.05 -1.031 . . . . 0.0 112.641 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -110.88 -4.71 15.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p -144.89 154.83 43.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.4 tpt -148.1 151.28 35.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.81 2.044 . . . . 0.0 108.73 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 54.83 37.44 62.01 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 114.946 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 58.93 26.73 15.33 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.089 1.756 . . . . 0.0 114.202 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 -141.57 156.74 45.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.7 2.0 . . . . 0.0 110.775 -173.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 44' ' ' HIS . 9.3 mp -75.39 -40.76 57.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -80.68 -48.05 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.177 0.898 . . . . 0.0 111.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.311 39.8 t60 49.71 26.76 1.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 128.267 2.627 . . . . 0.0 115.867 161.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 p 164.01 66.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.473 3.109 . . . . 0.0 110.636 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.25 -179.33 35.52 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.685 2.564 . . . . 0.0 115.453 11.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.285 3.99 . . . . 0.0 114.866 167.037 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.3 tpt -80.63 26.76 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.582 1.553 . . . . 0.0 114.591 -163.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.53 -32.92 59.13 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -161.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.87 174.28 22.46 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 125.01 1.291 . . . . 0.0 113.465 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.11 172.41 61.92 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 118.663 1.231 . . . . 0.0 114.163 3.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -72.89 151.77 41.77 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.656 1.183 . . . . 0.0 111.497 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.76 -164.65 13.43 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 127.082 2.277 . . . . 0.0 113.045 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.2 14.62 0.1 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.61 53.91 0.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.807 2.043 . . . . 0.0 112.494 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.17 -163.48 47.11 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.94 -158.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -122.69 41.01 3.55 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.215 1.406 . . . . 0.0 110.039 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 83' ' ' ILE . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.681 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.459 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -147.84 100.28 3.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.75 95.43 0.24 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 109.828 -176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? 27.55 59.19 0.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.464 2.706 . . . . 0.0 115.048 -163.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 66.71 -3.54 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.375 2.27 . . . . 0.0 115.692 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.66 -31.72 48.84 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.537 1.065 . . . . 0.0 114.148 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -162.51 153.14 17.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.618 1.567 . . . . 0.0 110.828 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -59.2 135.74 57.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.155 158.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p -87.42 6.18 35.16 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -123.81 156.22 36.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 14.9 tpt -146.33 146.45 30.69 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.075 1.35 . . . . 0.0 110.559 163.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.96 -81.83 0.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.379 1.466 . . . . 0.0 112.442 -171.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -156.55 19.66 0.34 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.152 1.781 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.82 156.27 41.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.373 1.869 . . . . 0.0 110.157 -156.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.517 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 96' ' ' VAL . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp -69.61 -15.71 63.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.28 -52.64 2.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 126.318 1.847 . . . . 0.0 110.175 -174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.261 77.6 t60 40.66 45.93 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.677 3.191 . . . . 0.0 114.692 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -157.94 -2.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.802 1.641 . . . . 0.0 115.222 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 167.22 53.91 0.03 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--O 1.248 0.985 0 CA-C-N 122.441 3.121 . . . . 0.0 109.985 -14.367 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.4 -57.63 7.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -157.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.34 -30.54 22.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.093 2.957 . . . . 0.0 112.645 -14.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.93 -53.71 0.42 Allowed Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.496 1.522 . . . . 0.0 113.72 164.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.89 -22.04 22.71 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.678 3.585 . . . . 0.0 116.125 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.37 1.45 2.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.434 1.494 . . . . 0.0 114.525 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.91 -25.93 0.03 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.94 -45.71 1.98 Allowed Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 165.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.49 -26.26 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.79 159.87 24.63 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 122.156 0.865 . . . . 0.0 114.818 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -85.11 32.55 0.54 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.025 1.73 . . . . 0.0 113.843 -167.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 27' ' ' VAL . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 78' ' ' MET . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 24' ' ' VAL . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -138.52 138.72 38.3 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -117.4 33.49 5.6 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -122.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER 41.52 40.93 1.46 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.01 1.724 . . . . 0.0 113.96 -168.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -153.64 -18.68 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.64 1.576 . . . . 0.0 114.524 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.05 40.34 7.08 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.375 0.989 . . . . 0.0 112.672 -171.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -153.15 144.96 23.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.317 1.847 . . . . 0.0 109.428 -170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -81.26 144.9 31.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.093 0.949 . . . . 0.0 111.381 160.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p -84.94 -12.12 54.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -162.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.699 ' CE1' HG21 ' A' ' 96' ' ' VAL . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 43' ' ' VAL . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 67' ' ' VAL . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -143.77 152.4 41.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 2.7 tpt -151.93 147.14 26.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.198 1.799 . . . . 0.0 110.982 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.96 33.23 82.99 Favored Glycine 0 CA--C 1.541 1.681 0 O-C-N 121.61 -0.681 . . . . 0.0 113.455 -167.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 56.54 32.06 20.15 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 114.112 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -147.28 153.72 40.09 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 96' ' ' VAL . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.699 HG21 ' CE1' ' A' ' 58' ' ' PHE . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.87 -14.64 62.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -39.59 28.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.563 1.145 . . . . 0.0 110.561 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -71.39 45.79 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 129.06 2.944 . . . . 0.0 112.926 169.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 m -152.22 178.82 9.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.455 1.502 . . . . 0.0 112.62 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.81 -155.36 7.25 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.703 1.62 . . . . 0.0 111.95 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.693 2.929 . . . . 0.0 112.273 167.223 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 tpt 60.45 -48.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.71 2.404 . . . . 0.0 115.277 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.3 tp -150.09 -16.4 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 114.888 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.45 29.65 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.356 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -87.53 -15.98 26.66 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 120.092 1.946 . . . . 0.0 113.943 -1.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -27.87 69.13 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.93 -2.62 0.21 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.612 -1.66 . . . . 0.0 117.223 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.99 -173.85 25.94 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 120.995 2.398 . . . . 0.0 116.565 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -45.0 8.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.236 174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.45 -154.35 24.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.823 0.725 . . . . 0.0 113.059 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -124.09 38.72 4.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.606 1.962 . . . . 0.0 110.441 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HB3' HD21 ' A' ' 18' ' ' LEU . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 15' ' ' LEU . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 83' ' ' ILE . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.752 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 46' ' ' ILE . 39.2 m-85 -160.24 138.86 10.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.3 p -110.48 14.27 22.56 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -160.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -116.92 -149.7 0.45 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 116.555 -3.841 . . . . 0.0 113.233 38.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 0.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -156.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -109.93 1.08 30.15 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.668 1.604 . . . . 0.0 115.272 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -146.48 77.77 1.49 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.652 1.226 . . . . 0.0 112.387 -160.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -52.53 124.51 13.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.454 1.501 . . . . 0.0 112.745 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p -82.4 -5.23 58.51 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 67' ' ' VAL . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB3' HD22 ' A' ' 61' ' ' LEU . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.756 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 164.96 14.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -14.87 11.86 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.45 -0.781 . . . . 0.0 112.803 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.58 112.97 0.43 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.339 1.924 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.7 m80 59.8 -7.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.356 2.262 . . . . 0.0 117.093 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -151.39 155.38 38.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.288 1.835 . . . . 0.0 112.15 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 96' ' ' VAL . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.05 -10.3 59.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -145.38 60.13 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 110.44 -151.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.48 -6.42 4.2 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -140.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.6 t -161.06 -18.06 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.0 66.58 0.01 OUTLIER Glycine 0 CA--C 1.541 1.685 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.575 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 C--O 1.247 0.937 0 CA-C-N 120.815 2.307 . . . . 0.0 111.103 2.343 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.7 mtp -137.63 -11.3 1.59 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.9 -7.18 5.54 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 -163.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.86 -79.5 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.909 -0.939 . . . . 0.0 113.981 158.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 -21.1 30.12 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.184 2.59 . . . . 0.0 111.06 161.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -76.75 75.34 3.4 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 148.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -0.13 105.56 0.01 OUTLIER Glycine 0 N--CA 1.478 1.494 1 C-N-CA 131.231 4.253 . . . . 0.0 118.366 -169.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.7 1.19 21.7 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.209 1.385 . . . . 0.0 116.155 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 -20.81 4.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.186 1.493 . . . . 0.0 113.924 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.02 -168.68 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.46 1.505 . . . . 0.0 112.052 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -123.46 36.33 4.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 112.476 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 43' ' ' VAL . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 83' ' ' ILE . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.42 ' CB ' HD21 ' A' ' 97' ' ' LEU . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.8 110.27 7.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -66.84 178.98 1.18 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.134 0.974 . . . . 0.0 111.909 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -24.25 54.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.841 0.857 . . . . 0.0 113.156 169.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.35 -10.39 59.54 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.388 1.075 . . . . 0.0 113.538 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.58 41.69 28.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.216 -0.927 . . . . 0.0 112.542 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -150.96 149.02 29.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.802 1.641 . . . . 0.0 110.999 -160.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -66.95 123.46 20.27 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.079 -1.013 . . . . 0.0 113.434 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -74.16 11.28 0.96 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.086 1.754 . . . . 0.0 115.089 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 64' ' ' GLU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p -128.31 153.43 47.0 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.43 115.45 5.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.867 1.667 . . . . 0.0 107.767 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.6 -168.59 53.8 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.776 0.703 . . . . 0.0 112.198 -157.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -72.47 30.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.583 1.553 . . . . 0.0 113.038 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -148.67 147.3 28.76 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.41 2.284 . . . . 0.0 110.737 -155.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 44' ' ' HIS . 8.0 mp -67.95 -18.45 64.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -145.05 48.24 1.3 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 123.824 1.773 . . . . 0.0 108.731 -141.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -81.65 13.93 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.733 -136.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.1 p -142.88 11.23 1.81 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.303 2.241 . . . . 0.0 113.808 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.69 169.34 32.34 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 116.177 1.231 . . . . 0.0 116.177 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.252 1.198 1 C-N-CA 125.37 4.047 . . . . 0.0 114.085 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt 138.94 -18.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 1 C-N-CA 132.188 4.195 . . . . 0.0 110.639 -164.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.12 172.71 12.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.318 1.847 . . . . 0.0 113.173 -160.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.74 -33.41 1.58 Allowed Glycine 0 CA--C 1.547 2.045 0 N-CA-C 119.311 2.485 . . . . 0.0 119.311 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.37 -11.69 3.26 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.144 3.229 . . . . 0.0 117.055 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.01 161.25 32.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.683 1.593 . . . . 0.0 112.209 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.01 109.42 0.8 Allowed Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.882 1.23 . . . . 0.0 113.355 -170.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.07 39.15 1.47 Allowed Glycine 0 CA--C 1.532 1.109 0 O-C-N 119.11 -2.406 . . . . 0.0 113.446 -21.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -128.96 3.66 5.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.614 2.366 . . . . 0.0 114.631 23.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.53 60.6 0.1 Allowed Glycine 0 N--CA 1.47 0.945 0 O-C-N 121.066 -1.021 . . . . 0.0 114.63 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.27 45.75 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.744 2.018 . . . . 0.0 114.625 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG13 HG21 ' A' ' 43' ' ' VAL . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 24' ' ' VAL . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 31' ' ' LEU . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 30' ' ' PHE . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 36' ' ' ILE . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.465 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -137.94 146.01 42.72 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -125.87 46.88 2.32 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -160.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -0.06 2.77 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.276 -3.39 . . . . 0.0 113.922 16.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.76 -28.97 2.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -153.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.74 28.16 0.25 Allowed Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.683 1.135 . . . . 0.0 113.948 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -158.91 120.15 3.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.076 1.35 . . . . 0.0 111.011 -162.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -61.31 165.38 4.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.261 172.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -134.57 168.91 18.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.403 1.481 . . . . 0.0 110.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 27' ' ' VAL . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 67' ' ' VAL . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.664 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -145.89 160.32 41.97 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 tpt -150.0 84.09 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.357 1.063 . . . . 0.0 112.422 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.29 1.38 7.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.697 3.046 . . . . 0.0 113.385 -5.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -126.14 4.9 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.654 1.982 . . . . 0.0 111.676 171.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.81 149.57 38.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.444 2.697 . . . . 0.0 109.985 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 96' ' ' VAL . 11.0 mp -77.12 -3.86 41.51 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -120.49 8.27 10.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.831 2.452 . . . . 0.0 111.649 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -57.95 -18.17 21.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 129.401 3.08 . . . . 0.0 114.585 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -58.43 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.039 1.736 . . . . 0.0 112.438 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.11 63.68 0.06 OUTLIER Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.348 1.452 . . . . 0.0 114.177 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.249 1.073 0 CA-C-N 120.222 2.011 . . . . 0.0 113.396 1.559 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.0 mmt -59.57 -26.77 65.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.689 1.196 . . . . 0.0 112.545 169.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -131.58 160.98 33.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.825 2.05 . . . . 0.0 111.44 159.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 20.49 67.07 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 128.353 2.882 . . . . 0.0 118.641 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.63 151.14 86.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.718 2.946 . . . . 0.0 113.79 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.64 -34.4 0.92 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.72 -43.75 0.03 OUTLIER Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.912 1.233 . . . . 0.0 115.036 -176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.37 -18.9 0.27 Allowed Glycine 0 CA--C 1.544 1.885 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -61.45 -24.51 66.6 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.579 2.19 . . . . 0.0 113.784 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.45 178.77 38.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.756 2.122 . . . . 0.0 109.148 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -117.25 31.55 6.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.229 1.412 . . . . 0.0 110.39 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.673 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 83' ' ' ILE . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.673 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 97' ' ' LEU . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -138.46 151.81 47.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.81 -21.24 48.01 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -150.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -111.7 152.69 27.44 Favored 'General case' 0 N--CA 1.48 1.04 2 C-N-CA 132.367 4.267 . . . . 0.0 110.017 -17.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -81.28 -177.61 6.55 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.888 2.475 . . . . 0.0 110.154 -21.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.7 -58.1 0.57 Allowed Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.117 0.865 . . . . 0.0 113.935 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -155.52 169.14 24.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.291 1.437 . . . . 0.0 111.03 -170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -66.89 166.43 13.45 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.51 0.671 . . . . 0.0 111.606 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t -123.68 176.64 6.12 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.905 1.682 . . . . 0.0 109.406 167.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 ' HB ' ' A' ' 43' ' ' VAL . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.606 ' HA ' HG13 ' A' ' 67' ' ' VAL . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p -127.54 152.15 47.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.1 tpt -151.5 153.54 34.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.199 1.399 . . . . 0.0 111.046 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.09 -79.69 0.39 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.848 1.213 . . . . 0.0 111.123 -166.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -156.34 15.11 0.32 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.736 1.615 . . . . 0.0 112.894 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -140.01 156.91 46.4 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.835 2.054 . . . . 0.0 111.819 -158.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.451 HG21 ' CE2' ' A' ' 30' ' ' PHE . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.432 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp -68.67 -11.24 59.92 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -98.56 -18.81 17.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.376 1.47 . . . . 0.0 113.034 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -53.8 135.7 41.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.84 2.056 . . . . 0.0 114.028 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.49 -34.66 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.969 1.308 . . . . 0.0 112.348 162.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.85 80.42 0.03 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.853 2.168 . . . . 0.0 111.829 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.253 1.23 0 CA-C-N 120.925 2.362 . . . . 0.0 116.469 0.823 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.5 mmt 59.77 24.4 13.35 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.708 2.003 . . . . 0.0 116.323 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -149.01 173.13 13.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.896 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 174.47 12.85 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.598 1.57 . . . . 0.0 115.401 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.84 -4.23 58.02 Favored 'Cis proline' 0 CA--C 1.546 1.079 0 CA-C-N 118.553 1.177 . . . . 0.0 114.651 3.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -61.76 -43.73 98.29 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 -2.35 0.19 Allowed Glycine 0 CA--C 1.541 1.7 0 C-N-CA 130.131 3.729 . . . . 0.0 114.547 -14.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.79 20.96 0.9 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 118.924 1.362 . . . . 0.0 115.181 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 -34.17 0.22 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.484 1.914 . . . . 0.0 113.145 -169.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.13 140.23 3.56 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.477 1.037 . . . . 0.0 112.478 163.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.445 ' HB3' HG23 ' A' ' 67' ' ' VAL . 37.5 m-85 -75.69 56.51 0.92 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 112.787 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG22 HD11 ' A' ' 61' ' ' LEU . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 27' ' ' VAL . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 24' ' ' VAL . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 59' ' ' VAL . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.547 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 97' ' ' LEU . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -102.05 -159.85 0.75 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 p -135.54 172.81 12.47 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 120.461 -1.399 . . . . 0.0 110.238 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -53.65 -1.9 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 159.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.84 -0.34 9.61 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.598 2.359 . . . . 0.0 113.404 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.71 35.34 28.77 Favored Glycine 0 N--CA 1.476 1.347 0 O-C-N 120.94 -1.1 . . . . 0.0 115.179 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -147.49 135.97 21.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.425 1.49 . . . . 0.0 111.409 -161.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -60.13 144.7 49.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.139 0.881 . . . . 0.0 112.538 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -111.78 7.17 20.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.8 1.24 . . . . 0.0 113.249 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 43' ' ' VAL . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HA ' HD13 ' A' ' 61' ' ' LEU . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p -141.04 149.32 41.54 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 tpp -157.55 81.18 0.89 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.462 1.505 . . . . 0.0 110.624 168.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.66 -41.25 0.06 OUTLIER Glycine 0 N--CA 1.477 1.432 0 C-N-CA 127.893 2.663 . . . . 0.0 113.627 4.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -74.73 12.28 0.86 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.807 1.243 . . . . 0.0 112.662 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -154.54 158.44 39.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.512 2.725 . . . . 0.0 110.86 -161.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 93' ' ' MET . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 44' ' ' HIS . 10.1 mp -80.36 -30.0 37.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -76.05 -23.39 55.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.504 1.922 . . . . 0.0 112.841 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -39.52 -28.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.907 2.083 . . . . 0.0 114.692 153.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.1 p -129.92 13.73 5.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 114.641 -173.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.13 -172.32 39.95 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--O 1.255 1.351 1 C-N-CA 125.36 4.04 . . . . 0.0 115.058 171.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.8 mmm 56.33 34.45 24.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.221 1.808 . . . . 0.0 114.315 -175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.4 mt -122.25 -7.54 8.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.689 1.995 . . . . 0.0 113.77 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.69 -158.91 32.0 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.775 0.702 . . . . 0.0 114.259 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.93 112.68 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.977 2.451 . . . . 0.0 109.665 164.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -152.28 128.79 10.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.013 1.325 . . . . 0.0 111.296 -165.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.84 178.11 41.23 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 128.255 2.836 . . . . 0.0 109.998 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.45 -36.06 1.59 Allowed Glycine 0 N--CA 1.477 1.383 0 CA-C-N 118.231 1.015 . . . . 0.0 114.986 170.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -20.24 63.13 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.372 1.086 . . . . 0.0 111.879 157.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.43 -170.57 39.2 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.983 2.23 . . . . 0.0 111.411 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.99 42.08 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.377 2.271 . . . . 0.0 110.0 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -121.59 103.94 9.27 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -54.29 -49.7 69.01 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -148.9 -38.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -123.95 -32.57 3.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -166.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.15 44.74 0.02 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -149.62 152.1 34.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.527 1.131 . . . . 0.0 112.153 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -61.84 136.3 57.93 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -166.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t -93.27 178.61 5.67 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.146 0.978 . . . . 0.0 109.55 146.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.657 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 67' ' ' VAL . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p -132.22 157.59 43.95 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ptm -79.87 8.11 7.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.537 1.135 . . . . 0.0 113.555 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.32 -8.53 44.7 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.612 2.053 . . . . 0.0 113.871 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -151.14 -31.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.35 157.85 45.31 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.504 1.922 . . . . 0.0 111.648 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.657 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.3 mp -70.66 -13.95 62.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -110.69 -46.87 3.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.608 1.563 . . . . 0.0 111.516 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.258 1.6 t60 55.1 -36.06 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.867 3.667 . . . . 0.0 118.981 164.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -73.52 -7.85 53.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.793 1.633 . . . . 0.0 112.975 165.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.13 -176.99 46.53 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.793 1.663 . . . . 0.0 113.56 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 C-N-CA 124.898 3.732 . . . . 0.0 112.956 170.788 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt -53.74 -18.98 3.59 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.72 -10.59 28.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.933 1.693 . . . . 0.0 115.106 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.5 -109.03 0.26 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.421 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.52 -178.47 3.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.367 3.378 . . . . 0.0 113.247 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -116.34 78.33 1.19 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.609 1.564 . . . . 0.0 110.21 163.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.19 64.69 0.66 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.652 2.549 . . . . 0.0 113.996 1.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 -48.04 8.02 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 118.048 1.979 . . . . 0.0 118.048 169.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.26 109.34 13.27 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 131.756 4.023 . . . . 0.0 110.801 6.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.66 -7.02 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.723 1.154 . . . . 0.0 115.807 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.76 29.62 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.304 1.552 . . . . 0.0 113.327 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.628 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.473 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.45 119.5 16.49 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.5 p -64.6 166.09 9.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.564 0.746 . . . . 0.0 110.815 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -66.68 -4.4 8.77 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.03 -5.43 10.53 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.744 1.618 . . . . 0.0 114.805 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 58.88 0.49 Allowed Glycine 0 N--CA 1.475 1.253 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 164.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.8 ttm105 -148.4 147.64 29.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.82 1.648 . . . . 0.0 111.058 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -57.27 126.9 29.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.201 0.909 . . . . 0.0 111.044 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -81.73 9.52 7.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.334 1.453 . . . . 0.0 114.202 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -137.86 147.96 44.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 tpp -151.85 131.98 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.187 1.395 . . . . 0.0 109.921 163.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.41 -163.12 52.73 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.72 0.676 . . . . 0.0 112.249 -160.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -70.51 28.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.223 1.809 . . . . 0.0 113.454 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -153.08 163.86 39.07 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.801 1.64 . . . . 0.0 112.639 -140.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.0 mp -75.09 -37.55 61.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.03 -47.63 43.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.884 1.274 . . . . 0.0 111.633 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 28.25 62.22 0.12 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.84 2.456 . . . . 0.0 114.879 159.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.5 t -129.72 147.55 51.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.239 2.616 . . . . 0.0 111.723 1.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.97 175.87 46.97 Favored Glycine 0 CA--C 1.544 1.868 0 C-N-CA 125.416 1.484 . . . . 0.0 113.643 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.829 3.686 . . . . 0.0 113.008 -177.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HB3' HD21 ' A' ' 18' ' ' LEU . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 43' ' ' VAL . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 67' ' ' VAL . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.563 ' HB3' HD22 ' A' ' 61' ' ' LEU . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 96' ' ' VAL . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 58' ' ' PHE . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.662 HG13 HG21 ' A' ' 43' ' ' VAL . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.662 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.418 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 96' ' ' VAL . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 96' ' ' VAL . 10.7 mp . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 24' ' ' VAL . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.477 ' HB3' HD21 ' A' ' 97' ' ' LEU . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.804 0.335 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.536 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 96' ' ' VAL . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.2 mp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.052 0.93 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.6 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG2' HG22 ' A' ' 24' ' ' VAL . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.453 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 . . . . . 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' HG13 ' A' ' 67' ' ' VAL . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 121.988 0.899 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.453 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.1 mp . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 HD11 ' A' ' 61' ' ' LEU . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 HG11 ' A' ' 43' ' ' VAL . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 24' ' ' VAL . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.652 0.263 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 43' ' ' VAL . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.662 ' HA ' HG13 ' A' ' 67' ' ' VAL . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.696 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.989 0.424 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 58' ' ' PHE . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 43' ' ' VAL . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 24' ' ' VAL . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.495 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.206 0.527 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 44' ' ' HIS . 9.3 mp . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 122.275 1.036 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 83' ' ' ILE . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.681 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.459 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.517 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 96' ' ' VAL . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 27' ' ' VAL . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 73' ' ' LYS . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 24' ' ' VAL . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.699 ' CE1' HG21 ' A' ' 96' ' ' VAL . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 43' ' ' VAL . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 67' ' ' VAL . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 96' ' ' VAL . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.699 HG21 ' CE1' ' A' ' 58' ' ' PHE . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.932 0.872 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HB3' HD21 ' A' ' 18' ' ' LEU . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 15' ' ' LEU . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.752 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 83' ' ' ILE . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.752 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 46' ' ' ILE . 39.2 m-85 . . . . . 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 67' ' ' VAL . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB3' HD22 ' A' ' 61' ' ' LEU . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.756 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 121.234 0.54 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 96' ' ' VAL . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.616 0.722 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 43' ' ' VAL . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 83' ' ' ILE . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.42 ' CB ' HD21 ' A' ' 97' ' ' LEU . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 64' ' ' GLU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 44' ' ' HIS . 8.0 mp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG13 HG21 ' A' ' 43' ' ' VAL . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 24' ' ' VAL . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 31' ' ' LEU . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 30' ' ' PHE . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 36' ' ' ILE . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.465 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.947 0.404 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 27' ' ' VAL . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 67' ' ' VAL . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.664 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 121.301 0.572 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 96' ' ' VAL . 11.0 mp . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 121.602 0.715 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.673 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 83' ' ' ILE . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.673 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 97' ' ' LEU . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 ' HB ' ' A' ' 43' ' ' VAL . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.606 ' HA ' HG13 ' A' ' 67' ' ' VAL . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.451 HG21 ' CE2' ' A' ' 30' ' ' PHE . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.432 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.445 ' HB3' HG23 ' A' ' 67' ' ' VAL . 37.5 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.715 0.769 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.443 HG22 HD11 ' A' ' 61' ' ' LEU . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 27' ' ' VAL . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 24' ' ' VAL . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 59' ' ' VAL . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.547 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 97' ' ' LEU . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 . . . . . 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 43' ' ' VAL . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HA ' HD13 ' A' ' 61' ' ' LEU . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 93' ' ' MET . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 44' ' ' HIS . 10.1 mp . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 121.882 0.849 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.657 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 67' ' ' VAL . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.657 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.3 mp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.628 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.473 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.0 mp . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 122.506 1.146 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 ttp -155.68 -32.67 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.264 3.026 . . . . 0.0 110.298 -173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.56 153.95 51.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.197 2.599 . . . . 0.0 109.615 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.54 -162.11 33.16 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.019 0.768 . . . . 0.0 115.019 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.17 -29.04 1.83 Allowed 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 118.361 1.081 . . . . 0.0 114.663 -2.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -171.27 169.73 6.25 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.96 2.904 . . . . 0.0 108.748 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.72 49.26 0.22 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 37.53 0.34 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.673 1.606 . . . . 0.0 115.811 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.7 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 1 C-N-CA 133.998 4.919 . . . . 0.0 120.408 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.66 4.61 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.956 1.265 . . . . 0.0 114.676 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -81.94 27.41 0.47 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.956 1.378 . . . . 0.0 113.801 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 t -62.74 140.79 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 121.36 -0.837 . . . . 0.0 109.527 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.48 131.93 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.423 155.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 31.0 tttp -75.11 147.93 40.13 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 166.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HB3' HD21 ' A' ' 18' ' ' LEU . 1.1 mt -130.36 122.56 28.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.009 2.124 . . . . 0.0 107.591 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -136.24 135.4 39.01 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.806 0.842 . . . . 0.0 111.661 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.77 -30.33 5.34 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.791 1.186 . . . . 0.0 113.777 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -41.43 157.18 0.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 131.657 3.983 . . . . 0.0 116.675 -169.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.74 146.78 83.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 113.875 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -0.88 4.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.944 1.698 . . . . 0.0 114.285 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.4 p -134.98 4.07 3.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.124 1.37 . . . . 0.0 113.502 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.68 166.91 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.645 1.212 . . . . 0.0 114.123 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.2 p -152.6 169.07 23.59 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.883 2.073 . . . . 0.0 110.964 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.281 0.3 OUTLIER -49.3 -26.63 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 176.777 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -64.63 -27.96 69.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 121.149 1.795 . . . . 0.0 111.226 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.99 -26.56 36.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.099 2.16 . . . . 0.0 112.934 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 24' ' ' VAL . 5.7 m -71.98 -47.91 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 122.701 1.239 . . . . 0.0 107.916 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -65.82 -25.13 67.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 129.49 3.116 . . . . 0.0 113.959 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -84.34 -45.19 13.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.703 1.138 . . . . 0.0 112.677 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -56.72 -30.48 63.55 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.08 0.952 . . . . 0.0 111.858 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -124.72 48.54 1.96 Allowed 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 126.147 1.779 . . . . 0.0 112.165 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.4 p -56.51 -15.37 4.15 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 112.856 -1.975 . . . . 0.0 112.53 161.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -25.31 61.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.407 2.683 . . . . 0.0 114.036 164.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.85 161.25 35.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -141.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 m -93.0 -47.67 6.88 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.082 0.953 . . . . 0.0 113.488 -168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.8 mp 52.19 159.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.435 1.894 . . . . 0.0 111.153 -153.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -68.72 13.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 119.116 -2.24 . . . . 0.0 115.452 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -170.69 -49.49 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.752 2.421 . . . . 0.0 109.229 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.41 -49.52 0.76 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.859 2.171 . . . . 0.0 110.596 -173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.59 -17.72 1.71 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.387 1.075 . . . . 0.0 112.955 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.87 29.58 0.33 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.027 -1.045 . . . . 0.0 113.222 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.15 -7.33 1.53 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.608 1.575 . . . . 0.0 112.726 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -94.51 143.98 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.567 1.683 . . . . 0.0 110.538 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -144.52 147.85 33.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.47 1.908 . . . . 0.0 108.979 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -108.62 158.31 17.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.435 0.694 . . . . 0.0 109.564 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.99 154.22 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 124.215 1.96 . . . . 0.0 108.741 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -140.22 133.97 30.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 111.251 -2.704 . . . . 0.0 106.486 -156.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -67.87 -10.24 51.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.271 87.0 mtt-85 118.29 -0.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 131.9 4.08 . . . . 0.0 112.771 150.115 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.75 -25.51 1.65 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.112 1.765 . . . . 0.0 113.62 -170.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.81 37.88 0.03 OUTLIER Glycine 0 N--CA 1.474 1.207 0 N-CA-C 118.776 2.271 . . . . 0.0 118.776 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.89 152.06 13.06 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.283 1.433 . . . . 0.0 111.519 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -76.53 172.33 13.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.584 0.754 . . . . 0.0 111.779 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -134.44 168.86 18.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.16 1.784 . . . . 0.0 110.245 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.32 40.66 1.29 Allowed Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.491 1.043 . . . . 0.0 112.963 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.8 151.58 41.32 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.895 1.678 . . . . 0.0 110.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.22 174.37 10.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.058 1.743 . . . . 0.0 111.246 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.9 m-85 -151.22 138.82 19.63 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.875 1.67 . . . . 0.0 109.501 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 43' ' ' VAL . 98.0 t -141.16 107.51 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.959 1.704 . . . . 0.0 111.03 -167.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -60.1 95.93 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.131 1.773 . . . . 0.0 110.803 164.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 67' ' ' VAL . 7.4 mt -67.31 170.24 7.56 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.25 -0.906 . . . . 0.0 112.686 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 -2.78 63.93 Favored Glycine 0 CA--C 1.537 1.441 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -164.54 169.01 17.66 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.792 2.437 . . . . 0.0 108.742 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -72.07 -15.03 62.01 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 119.608 -1.933 . . . . 0.0 112.127 170.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.44 -27.59 46.53 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 119.687 -1.883 . . . . 0.0 111.061 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.563 ' HB3' HD22 ' A' ' 61' ' ' LEU . 11.1 m-20 -60.57 -42.56 96.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.979 -1.076 . . . . 0.0 111.552 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.4 m -56.52 -50.6 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 120.694 1.588 . . . . 0.0 111.712 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -54.82 -42.62 72.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.853 2.061 . . . . 0.0 113.468 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.8 mmt -59.11 -37.44 77.2 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.391 0.996 . . . . 0.0 112.2 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.43 -35.87 68.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.079 0.951 . . . . 0.0 113.131 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.97 -27.67 69.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -52.67 -27.48 17.54 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 119.62 1.1 . . . . 0.0 113.193 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -104.92 12.76 32.08 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.076 1.75 . . . . 0.0 113.736 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.46 10.38 0.06 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -161.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.67 25.7 0.45 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.068 2.147 . . . . 0.0 113.001 165.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.53 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.036 1.334 . . . . 0.0 112.348 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p -136.88 151.52 49.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.006 2.122 . . . . 0.0 111.347 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.2 tpt -146.62 104.84 3.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.963 1.305 . . . . 0.0 108.21 166.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 -172.22 33.49 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.81 1.195 . . . . 0.0 111.991 -157.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -73.53 32.69 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.02 1.328 . . . . 0.0 111.933 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 145.76 29.29 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.398 2.279 . . . . 0.0 109.752 -160.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -90.4 153.6 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.992 -171.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.9 mm -132.0 75.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.283 1.039 . . . . 0.0 108.851 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -68.26 133.56 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.723 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 t -119.74 110.29 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.467 0.707 . . . . 0.0 110.017 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 63.0 m-85 -96.21 146.53 24.61 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 122.109 0.957 . . . . 0.0 109.035 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 131.55 34.75 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.526 1.53 . . . . 0.0 107.415 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -137.64 177.41 7.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.644 1.577 . . . . 0.0 109.18 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -137.33 158.53 44.2 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.703 -0.623 . . . . 0.0 110.267 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -53.69 -35.36 61.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.258 0.623 . . . . 0.0 112.211 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -36.27 75.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 113.682 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.17 -50.83 12.11 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.414 1.086 . . . . 0.0 110.23 168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.469 ' HA ' HG22 ' A' ' 96' ' ' VAL . 36.0 ttp -55.51 -38.18 68.86 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.21 -32.0 73.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.64 1.176 . . . . 0.0 111.631 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -60.73 2.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.404 1.082 . . . . 0.0 109.562 166.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 58' ' ' PHE . 4.1 m -67.84 -33.36 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -160.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp -73.76 -41.58 62.28 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.493 1.117 . . . . 0.0 112.296 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -97.33 58.33 1.5 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 123.003 1.382 . . . . 0.0 111.543 -158.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -151.08 -4.49 0.3 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.626 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.1 p -70.92 -1.46 11.95 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.615 -1.303 . . . . 0.0 113.443 154.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.56 -170.96 33.88 Favored Glycine 0 CA--C 1.545 1.948 0 C-N-CA 127.0 2.238 . . . . 0.0 112.515 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--O 1.25 1.117 1 C-N-CA 125.956 4.438 . . . . 0.0 116.07 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.095 0.95 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.1 mtp -129.06 -30.43 2.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.729 2.012 . . . . 0.0 110.337 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.4 tp -154.2 -16.37 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 160.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.82 157.62 12.37 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 125.699 1.619 . . . . 0.0 113.444 165.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -86.08 6.99 63.53 Favored 'Cis proline' 0 CA--C 1.551 1.327 0 CA-C-N 119.801 1.8 . . . . 0.0 113.338 -11.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.89 163.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.179 2.192 . . . . 0.0 116.013 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 54.63 73.79 0.38 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.697 1.617 . . . . 0.0 115.543 167.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.36 -176.26 45.36 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 128.123 2.773 . . . . 0.0 111.773 5.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -22.26 26.89 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.596 1.158 . . . . 0.0 112.329 171.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.29 152.99 25.05 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.426 1.965 . . . . 0.0 110.558 158.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.07 43.34 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.693 1.197 . . . . 0.0 113.712 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.31 138.78 22.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.978 0.894 . . . . 0.0 110.002 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.92 133.54 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.793 153.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 50.0 tttp -79.92 149.29 30.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 167.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.57 138.81 53.96 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.796 1.239 . . . . 0.0 109.114 169.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -142.09 134.55 28.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.355 0.662 . . . . 0.0 112.249 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.3 -28.18 4.59 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.213 1.387 . . . . 0.0 113.361 177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.57 155.48 0.26 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 128.426 2.69 . . . . 0.0 114.901 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -54.32 156.16 14.38 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.206 2.604 . . . . 0.0 112.787 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.49 6.14 1.16 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -146.59 24.81 1.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.116 2.166 . . . . 0.0 112.07 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.6 t -56.97 161.09 3.16 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.591 1.556 . . . . 0.0 111.701 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.4 p -149.31 169.15 21.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.3 1.524 . . . . 0.0 113.707 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.662 HG13 HG21 ' A' ' 43' ' ' VAL . 3.1 t -41.32 -31.59 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 128.194 2.597 . . . . 0.0 117.931 163.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -79.87 -24.94 40.87 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 119.999 -1.688 . . . . 0.0 110.584 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 8.6 t0 -86.8 -22.77 25.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.466 2.306 . . . . 0.0 113.321 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -85.71 -38.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -74.25 -23.85 59.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.666 2.386 . . . . 0.0 114.198 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.5 t30 -70.1 -51.4 31.94 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.021 1.328 . . . . 0.0 110.655 162.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -55.27 -33.1 62.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.783 0.833 . . . . 0.0 111.989 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 11.3 mt -124.8 44.15 2.85 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.451 1.5 . . . . 0.0 112.812 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.6 t -58.59 -13.69 6.37 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 112.95 -1.932 . . . . 0.0 111.898 158.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.42 -21.72 60.4 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.304 2.242 . . . . 0.0 115.555 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.17 160.43 39.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -141.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 127.77 53.65 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.174 1.389 . . . . 0.0 109.55 171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -97.24 160.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -78.52 53.06 1.24 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.987 1.315 . . . . 0.0 112.187 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.48 -60.58 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 132.674 4.389 . . . . 0.0 108.985 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.11 -39.19 1.62 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.217 1.389 . . . . 0.0 113.482 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -133.13 -29.24 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.733 1.613 . . . . 0.0 111.209 175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.7 18.17 1.01 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.56 0.744 . . . . 0.0 112.245 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.59 -2.26 3.63 Favored Glycine 0 C--O 1.217 -0.95 0 C-N-CA 124.967 1.27 . . . . 0.0 110.59 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.662 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -107.09 153.35 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 119.567 1.683 . . . . 0.0 110.157 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.418 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.9 148.16 28.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.969 1.308 . . . . 0.0 108.55 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.49 138.65 54.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mm -89.37 150.6 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 123.8 1.762 . . . . 0.0 110.061 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -135.58 137.3 41.84 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 111.881 -2.418 . . . . 0.0 107.898 -156.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.402 ' N ' ' HA ' ' A' ' 49' ' ' ARG . 41.1 p -74.28 -28.34 61.15 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 -161.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HA ' ' N ' ' A' ' 48' ' ' THR . 1.1 mtt-85 -111.2 26.22 10.91 Favored 'General case' 0 N--CA 1.486 1.326 1 C-N-CA 133.984 4.913 . . . . 0.0 113.247 9.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 50' ' ' GLU 0.315 0.3 OUTLIER -74.97 46.16 0.29 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.802 1.641 . . . . 0.0 114.403 179.444 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.73 25.45 58.34 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.353 1.454 . . . . 0.0 114.62 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -150.93 154.34 36.97 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.759 1.224 . . . . 0.0 111.789 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.06 145.21 27.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.53 1.132 . . . . 0.0 112.439 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -79.92 166.44 21.64 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 152.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.28 50.02 3.67 Favored Glycine 0 N--CA 1.476 1.303 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -146.07 150.1 35.31 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.567 1.547 . . . . 0.0 110.673 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.14 173.27 17.07 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.551 1.54 . . . . 0.0 110.436 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -148.41 141.78 25.23 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.46 1.504 . . . . 0.0 107.917 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.5 t -143.57 109.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.365 -1.459 . . . . 0.0 109.438 -168.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.03 102.33 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.117 0.872 . . . . 0.0 110.298 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 21.6 mt -69.85 169.16 13.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.154 0.978 . . . . 0.0 112.232 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.95 -3.77 70.0 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.047 0.832 . . . . 0.0 114.698 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -160.17 173.49 15.69 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.189 2.196 . . . . 0.0 109.657 158.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -74.06 -23.43 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 119.765 -1.834 . . . . 0.0 112.488 170.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.42 -25.23 62.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.126 -1.609 . . . . 0.0 110.81 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -61.9 -44.5 96.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.888 0.875 . . . . 0.0 112.355 157.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.6 m -54.82 -46.45 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.924 1.693 . . . . 0.0 112.719 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -59.03 -39.85 83.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.911 2.485 . . . . 0.0 113.945 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 mmt -63.19 -31.47 72.62 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.477 1.035 . . . . 0.0 112.424 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -75.72 -36.59 59.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.648 0.779 . . . . 0.0 113.026 173.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.1 -26.48 64.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -46.87 -38.2 10.01 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.375 0.989 . . . . 0.0 112.31 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -99.04 13.16 33.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.51 2.324 . . . . 0.0 112.892 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -61.67 -0.47 0.44 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 119.769 3.248 . . . . 0.0 119.769 -163.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -148.81 20.28 1.01 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.663 2.385 . . . . 0.0 112.303 165.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.304 0.1 OUTLIER -87.2 -166.49 1.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.706 2.403 . . . . 0.0 109.696 176.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.4 p -137.91 155.88 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.136 2.174 . . . . 0.0 113.159 -164.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -8.07 59.07 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.81 -41.83 0.57 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.017 1.77 . . . . 0.0 113.133 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -153.68 19.48 0.53 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.032 1.333 . . . . 0.0 114.303 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -153.81 156.95 38.63 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.679 2.392 . . . . 0.0 109.666 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -89.15 148.96 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.775 1.274 . . . . 0.0 113.576 -170.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -137.32 79.16 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.596 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.15 115.1 6.46 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.08 -1.012 . . . . 0.0 109.257 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.31 127.65 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 77.1 m-85 -112.46 145.87 39.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.035 169.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -72.39 143.54 48.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.84 162.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -146.19 174.79 11.01 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.414 1.085 . . . . 0.0 109.228 -164.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -130.85 152.29 50.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.922 0.489 . . . . 0.0 111.232 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -41.96 86.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.477 0.711 . . . . 0.0 111.24 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.8 m -62.55 -44.86 95.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.708 2.003 . . . . 0.0 112.352 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.67 -46.47 82.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.166 0.986 . . . . 0.0 110.95 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 96' ' ' VAL . 11.5 tmm? -60.34 -42.35 95.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.366 1.066 . . . . 0.0 113.007 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.38 -21.83 65.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.918 -1.114 . . . . 0.0 112.169 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -57.57 4.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.956 0.903 . . . . 0.0 110.192 165.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 33.8 m -69.23 -32.71 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 96' ' ' VAL . 10.7 mp -70.66 -22.85 62.44 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.818 0.735 . . . . 0.0 112.608 175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.54 8.4 10.12 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.479 1.912 . . . . 0.0 112.825 -161.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -43.49 -27.77 0.31 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 129.155 2.982 . . . . 0.0 113.98 168.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.8 m -142.79 53.04 1.39 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.792 1.637 . . . . 0.0 111.118 162.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.69 -173.44 22.16 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.409 1.481 . . . . 0.0 116.184 -171.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 C--N 1.358 1.032 0 N-CA-C 118.297 2.383 . . . . 0.0 118.297 6.567 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.567 0.699 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.29 167.05 23.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.259 1.824 . . . . 0.0 109.447 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.42 133.03 55.33 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.793 0.837 . . . . 0.0 112.23 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.81 -78.31 0.04 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 128.539 2.971 . . . . 0.0 112.928 -10.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -63.38 -42.14 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.465 2.11 . . . . 0.0 110.639 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -149.19 -171.66 3.94 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.73 2.012 . . . . 0.0 106.11 149.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.92 -29.81 0.32 Allowed Glycine 0 N--CA 1.474 1.209 0 O-C-N 120.586 -1.321 . . . . 0.0 114.643 171.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.28 166.27 36.16 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.723 1.154 . . . . 0.0 112.708 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 38.92 50.92 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.655 2.382 . . . . 0.0 115.282 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 32.56 0.46 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.704 2.097 . . . . 0.0 115.946 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -74.11 29.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.318 2.247 . . . . 0.0 113.137 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.36 136.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.813 0.816 . . . . 0.0 109.033 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 m -117.09 130.7 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.097 156.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 24.6 tttp -82.09 145.52 30.13 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 126.179 1.792 . . . . 0.0 106.607 170.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.07 129.4 43.55 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 125.931 1.692 . . . . 0.0 107.814 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -134.23 136.24 43.52 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 111.066 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.82 -31.65 4.69 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.629 1.109 . . . . 0.0 113.383 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.43 155.1 0.13 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.906 2.882 . . . . 0.0 115.846 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -57.05 156.55 23.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.319 2.68 . . . . 0.0 113.818 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -65.23 8.39 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -149.94 27.09 0.79 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.042 2.137 . . . . 0.0 112.308 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.6 t -56.39 154.57 8.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 112.847 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 p -140.0 173.1 11.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.786 1.279 . . . . 0.0 112.565 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -78.46 -14.61 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -76.77 -37.2 56.29 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 120.816 -1.178 . . . . 0.0 107.981 167.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 -48.79 78.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.143 1.777 . . . . 0.0 112.871 169.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -35.45 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.568 1.147 . . . . 0.0 109.942 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -98.95 -23.16 15.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.657 1.183 . . . . 0.0 113.567 -171.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.24 -39.31 71.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.295 1.838 . . . . 0.0 111.654 163.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.57 -37.27 67.82 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.898 0.879 . . . . 0.0 110.836 167.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.74 47.06 1.3 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.96 1.362 . . . . 0.0 113.564 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.6 p -57.53 -14.81 5.67 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.342 -1.754 . . . . 0.0 112.945 165.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.83 -27.08 68.52 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.993 2.117 . . . . 0.0 113.864 165.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -130.84 151.23 51.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -138.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.88 130.61 39.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.488 1.115 . . . . 0.0 109.309 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 3.7 mm -107.26 155.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.273 1.029 . . . . 0.0 108.472 172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.14 113.95 26.34 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.814 1.246 . . . . 0.0 109.203 173.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 74.66 -4.93 2.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.326 2.25 . . . . 0.0 114.384 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.99 -54.35 3.46 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.657 2.075 . . . . 0.0 116.03 155.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.44 -5.34 2.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.114 2.166 . . . . 0.0 112.325 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.19 23.36 11.76 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.071 1.748 . . . . 0.0 110.927 159.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -8.2 11.07 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.739 1.638 . . . . 0.0 112.598 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 24' ' ' VAL . 18.0 m -129.55 139.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.95 2.5 . . . . 0.0 107.926 -156.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.477 ' HB3' HD21 ' A' ' 97' ' ' LEU . 1.8 m80 -149.65 136.14 19.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -165.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.17 147.54 35.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.697 . . . . 0.0 109.617 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.12 150.53 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 122.875 1.321 . . . . 0.0 107.685 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -142.39 118.8 10.89 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.15 -1.841 . . . . 0.0 106.544 -151.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.3 p -76.64 15.79 0.59 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -160.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.268 5.7 mmm180 57.24 -10.1 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.968 3.707 . . . . 0.0 116.707 -167.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.98 -33.28 75.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.602 1.561 . . . . 0.0 112.983 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.02 31.67 0.99 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.635 1.588 . . . . 0.0 114.217 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 ttm105 -154.88 149.65 26.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.07 1.348 . . . . 0.0 111.796 -165.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -60.01 137.29 58.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 111.044 171.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.7 t -74.49 171.24 14.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 109.523 159.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.9 43.4 3.1 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.585 -0.697 . . . . 0.0 111.801 160.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -140.99 147.27 38.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.567 1.147 . . . . 0.0 111.796 165.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 173.16 14.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.501 1.92 . . . . 0.0 110.419 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 49.9 m-85 -145.96 143.94 29.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.507 1.523 . . . . 0.0 109.748 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.69 113.26 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.674 1.99 . . . . 0.0 110.011 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -64.91 104.34 0.84 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.319 1.447 . . . . 0.0 110.747 164.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 15.1 mt -73.69 170.18 15.79 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.094 -1.004 . . . . 0.0 113.109 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.64 -7.36 78.84 Favored Glycine 0 CA--C 1.54 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 114.904 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -164.74 174.02 11.17 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.233 2.213 . . . . 0.0 110.222 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.9 tt0 -81.57 -10.66 59.39 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 119.943 -1.723 . . . . 0.0 112.898 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.31 -32.45 60.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 119.8 -1.812 . . . . 0.0 110.911 161.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -59.59 -47.08 86.98 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.552 -1.213 . . . . 0.0 111.7 160.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 64' ' ' GLU . 6.3 m -54.98 -49.79 68.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 120.805 1.639 . . . . 0.0 112.417 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -52.7 -43.84 65.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.9 2.08 . . . . 0.0 113.958 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -67.13 -19.89 65.68 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.24 -35.07 18.72 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.909 1.284 . . . . 0.0 113.447 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.26 -27.98 68.36 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.356 -1.465 . . . . 0.0 113.368 171.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -64.27 -17.53 63.71 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.404 -1.435 . . . . 0.0 113.331 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -101.25 13.71 34.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.664 2.386 . . . . 0.0 113.005 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.73 0.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 120.219 3.414 . . . . 0.0 120.219 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.53 28.17 0.28 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.028 2.131 . . . . 0.0 111.982 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.6 -168.23 0.06 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.264 1.426 . . . . 0.0 112.532 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.0 p -138.18 159.67 41.44 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.785 171.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 tpt -147.24 144.61 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.718 1.607 . . . . 0.0 110.814 170.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.99 -82.24 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.818 1.675 . . . . 0.0 112.891 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -137.88 -3.32 1.83 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.451 1.9 . . . . 0.0 112.933 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 -146.75 154.61 41.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.122 1.369 . . . . 0.0 111.692 -149.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -73.02 152.32 41.37 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 mm -137.09 75.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.768 1.27 . . . . 0.0 108.79 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.19 113.58 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.607 1.163 . . . . 0.0 110.343 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.24 125.22 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.887 0.875 . . . . 0.0 109.734 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 82.4 m-85 -111.93 146.57 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.477 1.511 . . . . 0.0 109.306 173.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -76.66 129.47 36.42 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.335 1.854 . . . . 0.0 106.598 167.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.536 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 13.6 t -137.23 -179.58 5.81 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.064 1.345 . . . . 0.0 109.529 -164.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -143.28 166.07 25.73 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.465 -0.772 . . . . 0.0 111.066 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.0 mtp85 -57.27 -31.93 66.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.646 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -45.11 89.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.246 1.384 . . . . 0.0 113.746 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -69.89 -47.79 61.17 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 109.937 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 96' ' ' VAL . 4.6 tmm? -61.04 -42.33 98.27 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.023 0.929 . . . . 0.0 111.763 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 -59.67 3.04 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.983 1.313 . . . . 0.0 109.879 167.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 58' ' ' PHE . 33.6 m -70.73 -26.58 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -162.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.2 mp -74.72 -13.78 60.65 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.018 1.327 . . . . 0.0 113.619 169.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -117.89 62.16 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.888 2.475 . . . . 0.0 109.645 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -144.1 109.12 4.99 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.53 . . . . 0.0 110.862 -153.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.7 m -147.25 69.25 1.15 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.598 3.159 . . . . 0.0 110.924 -0.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 -173.63 41.28 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 129.483 3.421 . . . . 0.0 111.432 3.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 C--O 1.251 1.149 0 CA-C-N 120.056 1.928 . . . . 0.0 113.898 -9.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.36 13.78 0.58 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -161.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 168.95 21.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.193 1.397 . . . . 0.0 113.049 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.47 -170.66 26.46 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.653 1.121 . . . . 0.0 113.159 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.5 145.6 11.84 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.49 3.46 . . . . 0.0 114.938 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.39 31.52 0.07 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 127.744 2.417 . . . . 0.0 114.982 -170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.62 68.13 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.555 1.55 . . . . 0.0 116.568 -171.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.11 -179.83 48.24 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.166 1.365 . . . . 0.0 112.928 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -144.84 -38.44 0.27 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.21 -172.67 13.24 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.993 1.282 . . . . 0.0 112.048 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.27 34.71 4.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.066 1.346 . . . . 0.0 111.7 -170.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 t -67.61 141.42 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.885 0.85 . . . . 0.0 110.114 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.76 127.52 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.693 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.6 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.3 tttp -74.59 150.5 39.66 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.298 1.439 . . . . 0.0 107.771 166.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -137.79 122.13 18.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 126.156 1.783 . . . . 0.0 106.914 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -133.43 115.94 15.43 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.324 0.583 . . . . 0.0 111.509 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 144.21 -20.56 2.1 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.13 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.74 159.37 0.18 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.659 2.783 . . . . 0.0 115.465 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -52.55 154.28 12.26 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.76 2.974 . . . . 0.0 115.382 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -8.39 3.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.771 1.628 . . . . 0.0 115.005 172.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.0 p -135.93 21.95 3.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.451 1.901 . . . . 0.0 112.776 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.5 t -55.88 151.48 11.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.064 1.346 . . . . 0.0 112.829 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -142.67 170.01 16.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 123.567 1.651 . . . . 0.0 113.254 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -39.55 -33.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 163.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -77.42 -27.42 52.31 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.746 -1.847 . . . . 0.0 110.528 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 6.0 t0 -79.99 -26.74 39.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.898 2.479 . . . . 0.0 113.697 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -86.65 -37.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -70.93 -36.79 72.79 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 113.656 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 1.7 t30 -60.85 -47.1 87.9 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 120.138 1.335 . . . . 0.0 111.984 167.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.99 -37.67 74.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.078 0.399 . . . . 0.0 111.169 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 mt -113.23 46.02 1.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 123.077 1.417 . . . . 0.0 112.681 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.8 p -64.8 43.49 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 129.455 3.102 . . . . 0.0 112.225 161.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -160.3 -18.8 0.06 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 131.195 3.798 . . . . 0.0 111.935 -159.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.0 154.05 45.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.153 1.381 . . . . 0.0 112.043 -157.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 130.19 43.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.076 0.95 . . . . 0.0 109.836 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -100.61 164.47 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.08 0.952 . . . . 0.0 108.457 168.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.284 0.0 OUTLIER -81.93 1.63 34.41 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -158.36 -56.58 0.07 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.64 2.376 . . . . 0.0 109.773 159.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.73 -39.59 1.33 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.765 1.65 . . . . 0.0 113.146 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.53 -29.99 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.525 1.53 . . . . 0.0 111.124 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.29 22.46 0.54 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.782 0.833 . . . . 0.0 111.577 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.33 17.75 2.28 Favored Glycine 0 C--N 1.341 0.808 0 C-N-CA 126.195 1.855 . . . . 0.0 109.507 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 ' CG2' HG22 ' A' ' 24' ' ' VAL . 3.2 m -130.06 150.54 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.375 1.47 . . . . 0.0 109.431 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.453 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -148.54 144.28 27.2 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.635 1.174 . . . . 0.0 108.552 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.95 146.02 47.96 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.356 0.662 . . . . 0.0 109.951 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mm -104.55 147.63 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 123.392 1.568 . . . . 0.0 108.589 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.02 124.93 27.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.886 -149.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -60.56 3.42 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.408 -165.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -150.11 -1.38 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.313 1.445 . . . . 0.0 113.425 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.19 -39.52 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.118 2.167 . . . . 0.0 112.014 -156.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.46 12.61 0.42 Allowed Glycine 0 N--CA 1.469 0.851 0 N-CA-C 118.066 1.987 . . . . 0.0 118.066 160.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -64.0 141.94 58.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.751 0.776 . . . . 0.0 110.89 157.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -71.58 123.27 22.12 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.64 0.776 . . . . 0.0 110.697 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -74.58 17.69 0.19 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.752 1.621 . . . . 0.0 114.287 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.46 38.93 9.67 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 124.88 1.228 . . . . 0.0 112.922 -157.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.48 142.8 33.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.322 1.449 . . . . 0.0 110.772 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 167.03 23.11 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.964 1.305 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.6 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 38.7 m-85 -141.53 138.64 32.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.508 1.523 . . . . 0.0 107.545 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.65 109.01 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.041 -1.662 . . . . 0.0 109.588 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.53 102.99 0.13 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.605 1.162 . . . . 0.0 110.946 160.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 17.3 mt -76.31 169.26 18.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.439 1.114 . . . . 0.0 113.074 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.02 -13.48 83.64 Favored Glycine 0 CA--C 1.541 1.702 0 O-C-N 121.102 -0.998 . . . . 0.0 115.18 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.0 p -166.53 171.06 12.16 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.62 2.368 . . . . 0.0 110.004 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' HG13 ' A' ' 67' ' ' VAL . 5.3 tt0 -73.94 -18.84 60.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.86 -1.775 . . . . 0.0 111.859 171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.33 -30.6 67.61 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.957 -1.714 . . . . 0.0 111.391 166.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.15 -47.3 85.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.014 160.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -54.57 -51.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.913 1.688 . . . . 0.0 112.114 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -54.59 -40.86 69.23 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.524 2.73 . . . . 0.0 113.155 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.6 mtm -63.13 -47.11 84.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.2 0.909 . . . . 0.0 112.449 171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.52 72.13 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.34 -28.12 69.07 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.552 -1.343 . . . . 0.0 114.172 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -51.88 -29.68 20.82 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.18 1.355 . . . . 0.0 112.22 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -103.0 9.44 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.248 2.219 . . . . 0.0 113.154 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.58 13.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -162.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 14.62 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.262 2.225 . . . . 0.0 113.764 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.289 6.0 pt-20 -86.76 -164.67 1.1 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.721 0.692 . . . . 0.0 112.178 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -141.03 153.14 45.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.488 1.915 . . . . 0.0 113.563 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -5.94 59.23 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 -36.91 0.63 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.231 1.872 . . . . 0.0 112.554 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.15 -24.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.916 1.286 . . . . 0.0 114.017 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -115.97 151.94 34.45 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.777 1.631 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -95.76 149.07 21.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.239 -162.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 mm -131.47 84.51 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 24.7 tt0 -71.42 113.77 8.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.013 171.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -93.5 99.69 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.822 0.849 . . . . 0.0 108.977 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 66.5 m-85 -84.96 148.44 26.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 167.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -78.21 143.27 37.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 176.53 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 110.016 -167.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -145.97 161.37 40.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.538 1.135 . . . . 0.0 109.844 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -74.58 47.7 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.773 -1.205 . . . . 0.0 112.815 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.8 m -144.85 -57.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.467 1.907 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -30.96 54.29 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.961 1.255 . . . . 0.0 111.706 172.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -59.49 -44.58 93.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.015 0.912 . . . . 0.0 112.365 165.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.23 -38.5 83.58 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.018 0.927 . . . . 0.0 111.817 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -54.0 51.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.344 1.457 . . . . 0.0 110.539 171.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.9 m -72.99 -27.19 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -167.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.453 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.1 mp -71.59 -8.67 55.45 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -116.91 -10.3 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.474 1.51 . . . . 0.0 113.573 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -54.41 -35.51 62.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.25 1.42 . . . . 0.0 113.098 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.4 p -80.47 -53.09 6.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.68 1.592 . . . . 0.0 115.088 -167.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 35.56 80.15 0.02 OUTLIER Glycine 0 CA--C 1.548 2.141 0 C-N-CA 127.647 2.546 . . . . 0.0 118.382 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.252 1.194 0 CA-C-N 120.619 2.209 . . . . 0.0 113.553 -7.303 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -140.16 149.96 43.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.143 0.977 . . . . 0.0 112.79 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 tp -126.06 -6.4 6.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.404 2.282 . . . . 0.0 112.314 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -163.82 34.32 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 126.214 1.864 . . . . 0.0 110.917 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.93 30.9 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.388 0 C-N-CA 124.278 3.318 . . . . 0.0 111.832 163.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.62 -40.79 1.73 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -151.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.85 16.71 0.07 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.447 2.927 . . . . 0.0 116.74 0.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.93 -8.0 75.04 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 120.637 2.219 . . . . 0.0 117.721 165.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.45 30.81 0.29 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.781 1.791 . . . . 0.0 113.235 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.9 -175.68 17.55 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 127.514 2.483 . . . . 0.0 111.131 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -119.23 36.9 4.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.007 0.923 . . . . 0.0 110.713 165.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.77 139.61 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.599 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 HD11 ' A' ' 61' ' ' LEU . 35.2 m -120.82 134.0 65.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.925 150.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 43.7 tttt -71.59 146.5 48.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 165.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.26 122.54 34.18 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.2 2.2 . . . . 0.0 107.598 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.71 139.04 27.67 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.816 0.846 . . . . 0.0 110.229 -163.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.31 -27.66 14.97 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.774 0.702 . . . . 0.0 113.174 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -34.74 154.43 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 130.791 3.637 . . . . 0.0 115.409 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 151.89 57.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.198 1.932 . . . . 0.0 111.922 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -75.3 17.34 0.26 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.583 1.153 . . . . 0.0 113.481 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.8 p -143.08 15.1 1.89 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.96 2.504 . . . . 0.0 112.955 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.83 154.53 18.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.864 1.665 . . . . 0.0 114.213 -170.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -124.76 168.05 13.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.03 1.732 . . . . 0.0 111.048 169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG22 HG11 ' A' ' 43' ' ' VAL . 2.3 t -42.1 -43.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 151.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -77.4 -27.14 52.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 119.589 -1.944 . . . . 0.0 109.345 -166.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -56.12 26.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.571 2.348 . . . . 0.0 112.828 158.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -27.5 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.5 1.92 . . . . 0.0 111.252 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -116.56 -11.47 11.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.32 -44.66 74.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.441 1.496 . . . . 0.0 111.307 147.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.85 -33.95 71.03 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.195 -0.94 . . . . 0.0 111.725 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.3 mt -114.84 43.83 1.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 123.088 1.423 . . . . 0.0 112.274 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 p -55.91 -14.31 2.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.966 -1.924 . . . . 0.0 113.201 162.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.66 -23.63 64.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.239 2.616 . . . . 0.0 114.257 167.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 158.48 43.83 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -141.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -108.78 129.82 55.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.22 1.408 . . . . 0.0 110.155 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 5.2 mm -104.13 153.18 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 7.9 t-80 -77.81 64.0 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.926 0.89 . . . . 0.0 112.195 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t70 132.66 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 1 C-N-CA 133.343 4.657 . . . . 0.0 108.665 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.07 -118.59 4.03 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -154.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.21 68.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.51 6.55 12.09 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.629 1.104 . . . . 0.0 113.508 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.35 23.45 5.15 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.172 1.844 . . . . 0.0 111.933 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.692 HG11 HG22 ' A' ' 24' ' ' VAL . 3.6 p -135.82 157.93 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.337 1.855 . . . . 0.0 109.96 165.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.7 m80 -149.59 139.69 22.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.314 1.846 . . . . 0.0 108.805 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -120.25 131.17 54.82 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 110.357 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.9 153.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 123.527 1.632 . . . . 0.0 110.536 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.46 133.1 36.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.34 -159.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 p -74.88 24.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -161.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 76.53 3.65 3.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.926 2.89 . . . . 0.0 114.513 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.87 -35.89 1.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.78 24.14 0.02 OUTLIER Glycine 0 N--CA 1.478 1.468 0 N-CA-C 120.029 2.772 . . . . 0.0 120.029 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -153.64 152.51 30.93 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.048 1.924 . . . . 0.0 112.645 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -63.22 161.82 13.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -132.52 173.55 11.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.06 1.744 . . . . 0.0 110.864 164.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.39 36.62 1.35 Allowed Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.879 1.228 . . . . 0.0 114.581 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -136.13 149.73 48.78 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.015 1.326 . . . . 0.0 110.849 171.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -165.93 175.41 8.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.251 2.22 . . . . 0.0 109.998 -172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 56.6 m-85 -149.49 139.21 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.735 1.614 . . . . 0.0 109.074 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 43' ' ' VAL . 43.6 t -130.43 109.38 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.207 2.203 . . . . 0.0 108.986 -172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -67.28 97.89 0.58 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.946 0.898 . . . . 0.0 110.331 160.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.1 mp -66.75 171.23 5.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.358 1.075 . . . . 0.0 113.038 174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -95.83 -0.28 62.33 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.936 1.255 . . . . 0.0 115.118 -174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t -160.13 175.22 13.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.171 2.188 . . . . 0.0 109.066 156.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.662 ' HA ' HG13 ' A' ' 67' ' ' VAL . 15.5 tt0 -78.4 -24.16 46.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.101 -1.624 . . . . 0.0 112.157 170.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.05 -30.51 71.65 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.55 -1.344 . . . . 0.0 110.559 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -65.82 -39.25 90.66 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.259 -0.9 . . . . 0.0 112.751 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.696 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.0 m -57.33 -54.14 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.695 1.589 . . . . 0.0 111.474 171.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -52.33 -46.37 66.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.326 2.651 . . . . 0.0 113.528 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 41.7 mtm -67.57 -23.32 65.4 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.69 -36.89 25.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.728 1.211 . . . . 0.0 112.575 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 mt -63.36 -30.51 71.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.617 -1.302 . . . . 0.0 113.471 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -61.47 -19.65 62.26 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.905 -1.122 . . . . 0.0 112.88 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -93.09 6.72 46.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.726 1.61 . . . . 0.0 114.465 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.18 4.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 -164.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.88 5.06 0.76 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.847 2.059 . . . . 0.0 115.514 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.286 5.1 pt-20 -78.27 -160.82 0.22 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.74 1.155 . . . . 0.0 112.213 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.6 p -146.13 157.15 43.83 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -162.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.67 146.94 22.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.489 2.316 . . . . 0.0 109.731 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.82 37.45 93.68 Favored Glycine 0 CA--C 1.539 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 114.38 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 58.6 25.19 12.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.405 1.882 . . . . 0.0 114.663 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -139.54 154.33 47.64 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.491 1.916 . . . . 0.0 111.31 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.2 143.76 36.88 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.111 0.957 . . . . 0.0 111.661 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 mm -128.82 74.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 123.19 1.472 . . . . 0.0 107.873 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.19 138.03 57.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.441 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.85 100.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.996 0.919 . . . . 0.0 109.912 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.2 m-85 -92.58 143.61 26.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.339 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -70.57 135.66 48.67 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.534 1.134 . . . . 0.0 107.982 165.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -148.36 168.41 22.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.652 0.781 . . . . 0.0 109.964 -166.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -122.57 154.43 37.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.848 0.459 . . . . 0.0 110.735 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -60.32 -44.68 95.25 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.149 -0.969 . . . . 0.0 112.224 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.4 m -69.75 -36.78 76.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.337 1.055 . . . . 0.0 112.95 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -60.06 -50.97 71.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.491 0.716 . . . . 0.0 110.34 169.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -58.07 -40.56 81.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.163 0.985 . . . . 0.0 113.107 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.79 -30.47 71.47 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.966 1.306 . . . . 0.0 112.286 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 -58.49 4.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.891 1.277 . . . . 0.0 110.658 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 58' ' ' PHE . 21.1 m -71.57 -34.16 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp -66.06 -17.13 64.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 114.331 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -127.21 -52.73 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 124.858 1.263 . . . . 0.0 110.251 -154.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.0 t60 59.85 -52.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.631 2.773 . . . . 0.0 116.677 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m -152.94 1.93 0.29 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.147 2.179 . . . . 0.0 113.783 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -122.76 1.01 Allowed Glycine 0 CA--C 1.543 1.817 0 C-N-CA 125.371 1.462 . . . . 0.0 111.188 -174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.252 1.184 0 C-N-CA 122.89 2.393 . . . . 0.0 111.805 161.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.8 mtt 53.82 -54.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 130.628 3.571 . . . . 0.0 117.462 -170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.39 39.45 0.29 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.816 1.647 . . . . 0.0 111.381 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.17 154.55 25.5 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 125.859 1.695 . . . . 0.0 112.289 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -88.19 -5.39 6.64 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.177 3.251 . . . . 0.0 114.805 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -6.72 25.67 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.79 178.55 48.77 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.619 2.533 . . . . 0.0 110.454 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 166.41 34.36 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.993 1.397 . . . . 0.0 116.151 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.46 -7.65 1.14 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 115.179 -165.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.23 166.99 25.09 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 122.159 0.866 . . . . 0.0 114.597 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -107.17 80.74 1.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.192 1.397 . . . . 0.0 111.236 -160.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.19 140.98 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.5 1.143 . . . . 0.0 111.404 -161.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.7 m -122.59 136.09 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.338 154.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 13.3 tttp -79.02 149.35 32.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.23 116.79 14.82 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.997 2.119 . . . . 0.0 107.598 -173.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -136.89 141.84 42.74 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.34 -28.15 8.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.046 1.308 . . . . 0.0 113.02 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -31.68 147.99 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.83 1 C-N-CA 132.256 4.222 . . . . 0.0 116.401 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.31 175.66 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.92 3.08 . . . . 0.0 114.55 -161.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -56.01 -23.58 33.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.299 1.439 . . . . 0.0 114.191 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.6 p -70.16 -23.91 63.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.491 1.917 . . . . 0.0 115.172 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.93 142.1 56.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -133.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -148.59 172.49 14.44 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 127.779 2.431 . . . . 0.0 109.262 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 43' ' ' VAL . 2.2 t -41.23 -48.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 157.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -75.18 -23.57 57.72 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 119.827 -1.796 . . . . 0.0 109.588 -167.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -53.41 55.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.672 1.989 . . . . 0.0 112.915 161.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -28.37 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.571 1.949 . . . . 0.0 111.331 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -115.53 -11.24 11.79 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.81 -47.85 65.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.275 1.43 . . . . 0.0 111.208 149.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.02 -34.41 70.01 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 121.34 -0.85 . . . . 0.0 111.529 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.08 44.85 2.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 123.023 1.392 . . . . 0.0 111.954 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.0 p -57.5 -15.15 6.25 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.919 161.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.98 -26.02 65.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.537 2.335 . . . . 0.0 113.756 164.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.76 145.49 49.85 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -139.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.58 125.69 35.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.174 1.39 . . . . 0.0 109.101 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.6 mp -98.66 155.74 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 163.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -66.96 13.98 0.05 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 126.227 1.811 . . . . 0.0 115.632 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -168.74 -57.06 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.18 2.592 . . . . 0.0 109.39 165.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.24 -46.59 0.69 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 126.918 2.199 . . . . 0.0 111.673 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.97 -25.08 1.85 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.696 1.598 . . . . 0.0 111.5 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.33 24.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 121.352 -0.843 . . . . 0.0 112.043 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.09 18.84 1.75 Allowed Glycine 0 C--O 1.221 -0.67 0 C-N-CA 126.498 1.999 . . . . 0.0 109.556 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 24' ' ' VAL . 4.1 m -128.46 152.69 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 125.578 1.551 . . . . 0.0 109.928 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.495 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.3 m80 -153.08 137.78 16.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.519 0.728 . . . . 0.0 109.288 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.1 136.26 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.441 0.696 . . . . 0.0 109.234 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.18 143.67 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 124.103 1.906 . . . . 0.0 109.215 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.85 118.66 16.18 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.006 -158.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -62.45 162.08 10.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.059 1.344 . . . . 0.0 111.268 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -61.98 -13.13 22.67 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -165.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 -3.13 14.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.196 1.799 . . . . 0.0 113.71 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.78 53.87 0.7 Allowed Glycine 0 N--CA 1.47 0.926 0 N-CA-C 116.281 1.272 . . . . 0.0 116.281 162.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -142.52 159.28 42.55 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.442 2.297 . . . . 0.0 110.128 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.93 154.09 42.12 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.05 -1.031 . . . . 0.0 112.641 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.7 p -110.88 -4.71 15.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.01 25.88 57.37 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.304 0.954 . . . . 0.0 113.464 -159.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -127.66 149.81 50.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.225 1.41 . . . . 0.0 111.763 167.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.19 173.34 11.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.72 2.008 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.8 m-85 -148.06 145.53 28.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.11 1.764 . . . . 0.0 107.747 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.0 109.57 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.302 -1.499 . . . . 0.0 108.452 -171.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.29 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.618 0.767 . . . . 0.0 110.603 157.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 11.5 mt -59.45 171.65 0.78 Allowed 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.043 -1.035 . . . . 0.0 111.25 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.41 -2.27 53.71 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 123.874 0.75 . . . . 0.0 114.937 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.2 p -160.01 169.88 22.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.231 1.812 . . . . 0.0 110.806 160.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.8 tm-20 -76.62 -13.58 60.05 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 119.772 -1.83 . . . . 0.0 112.841 173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.81 -30.22 58.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.748 -1.845 . . . . 0.0 110.82 164.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.41 -47.25 86.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.432 160.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -54.95 -50.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 120.335 1.425 . . . . 0.0 111.97 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -52.33 -47.58 65.95 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.971 2.108 . . . . 0.0 114.013 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.8 mtm -60.61 -34.2 73.88 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -35.96 63.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.835 1.254 . . . . 0.0 113.669 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.41 -28.78 69.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.597 1.159 . . . . 0.0 113.132 170.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.42 -32.31 26.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.004 1.274 . . . . 0.0 112.677 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -99.52 11.57 38.79 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.951 1.7 . . . . 0.0 113.234 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -62.15 7.56 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -168.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.3 10.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.472 2.309 . . . . 0.0 114.668 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.276 9.5 pt-20 -89.04 -156.71 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.317 0.508 . . . . 0.0 111.051 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.0 p -144.89 154.83 43.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -160.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.4 tpt -148.1 151.28 35.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.81 2.044 . . . . 0.0 108.73 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 54.83 37.44 62.01 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 114.946 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 58.93 26.73 15.33 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.089 1.756 . . . . 0.0 114.202 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.0 mmm-85 -141.57 156.74 45.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.7 2.0 . . . . 0.0 110.775 -173.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -79.14 146.41 33.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.853 1.311 . . . . 0.0 112.777 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.8 mm -126.88 82.52 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.1 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.11 134.49 56.5 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.252 -0.905 . . . . 0.0 108.982 158.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.89 106.42 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.563 0.745 . . . . 0.0 109.573 173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 53.5 m-85 -94.56 148.29 22.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.38 0.61 . . . . 0.0 109.842 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -65.55 137.97 57.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.122 1.369 . . . . 0.0 108.115 162.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 m -152.09 170.28 20.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -139.24 159.71 41.51 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.592 -0.692 . . . . 0.0 110.547 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -35.57 77.21 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -170.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -57.1 11.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 112.926 172.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.5 -42.64 82.55 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.945 0.339 . . . . 0.0 110.906 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -56.89 -43.01 80.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.772 0.796 . . . . 0.0 112.508 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -32.91 74.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.28 -0.888 . . . . 0.0 111.937 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -53.56 51.99 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.287 1.035 . . . . 0.0 110.009 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' CE1' ' A' ' 58' ' ' PHE . 24.5 m -72.89 -25.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -167.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 44' ' ' HIS . 9.3 mp -75.39 -40.76 57.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.305 1.042 . . . . 0.0 113.267 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -80.68 -48.05 13.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.177 0.898 . . . . 0.0 111.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.311 39.8 t60 49.71 26.76 1.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 128.267 2.627 . . . . 0.0 115.867 161.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 p 164.01 66.15 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.473 3.109 . . . . 0.0 110.636 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.25 -179.33 35.52 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.685 2.564 . . . . 0.0 115.453 11.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.285 3.99 . . . . 0.0 114.866 167.037 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.3 tpt -80.63 26.76 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.582 1.553 . . . . 0.0 114.591 -163.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.53 -32.92 59.13 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -161.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.87 174.28 22.46 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 125.01 1.291 . . . . 0.0 113.465 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.11 172.41 61.92 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 118.663 1.231 . . . . 0.0 114.163 3.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -72.89 151.77 41.77 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.656 1.183 . . . . 0.0 111.497 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.76 -164.65 13.43 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 127.082 2.277 . . . . 0.0 113.045 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.2 14.62 0.1 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.61 53.91 0.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.807 2.043 . . . . 0.0 112.494 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.17 -163.48 47.11 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.94 -158.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -122.69 41.01 3.55 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.215 1.406 . . . . 0.0 110.039 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.29 136.0 27.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.113 0.959 . . . . 0.0 110.0 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.89 158.5 16.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.466 154.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 20.2 tttp -123.22 115.6 22.01 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 108.016 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.0 mm? -94.78 123.52 38.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -136.25 121.53 19.19 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.139 -1.391 . . . . 0.0 113.752 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.5 -23.75 3.78 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.183 1.373 . . . . 0.0 113.615 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -41.9 159.72 0.18 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 129.671 3.188 . . . . 0.0 117.17 -172.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.59 146.98 81.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.037 2.491 . . . . 0.0 111.836 166.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -72.69 27.27 0.06 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.655 1.982 . . . . 0.0 113.716 171.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -151.73 30.25 0.59 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.666 2.387 . . . . 0.0 111.068 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.69 154.65 20.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.878 1.671 . . . . 0.0 111.405 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.7 p -150.65 165.85 32.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.291 1.436 . . . . 0.0 112.019 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.284 0.4 OUTLIER -57.4 -16.23 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 178.629 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -70.01 -32.04 70.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.523 -1.986 . . . . 0.0 110.544 167.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.08 -13.81 49.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.117 2.567 . . . . 0.0 113.774 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 24' ' ' VAL . 13.3 m -74.11 -43.0 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 123.186 1.47 . . . . 0.0 107.925 171.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.885 3.274 . . . . 0.0 113.89 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.17 -30.48 20.99 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.07 0.948 . . . . 0.0 111.592 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CE2' HG21 ' A' ' 83' ' ' ILE . 19.9 t80 -60.26 -37.65 81.1 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.826 1.194 . . . . 0.0 110.684 163.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 9.6 mt -119.34 52.31 1.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 123.906 1.812 . . . . 0.0 113.586 -177.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.2 p -56.26 -17.67 8.25 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 111.509 -2.587 . . . . 0.0 112.907 163.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.7 -25.63 67.53 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.89 2.476 . . . . 0.0 114.781 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.03 155.7 49.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -137.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.83 43.48 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.335 1.454 . . . . 0.0 109.682 171.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mm -92.68 161.26 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 163.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.7 6.46 0.47 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.0 2.12 . . . . 0.0 116.535 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.54 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.721 2.808 . . . . 0.0 109.418 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.35 -45.02 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.689 2.09 . . . . 0.0 111.445 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 -17.59 2.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.503 1.121 . . . . 0.0 113.345 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.52 46.09 1.03 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.9 1.333 . . . . 0.0 111.589 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.13 15.96 0.15 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 125.434 1.493 . . . . 0.0 112.601 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.681 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -124.11 145.15 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.696 2.248 . . . . 0.0 110.389 -176.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.459 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -145.89 154.9 42.48 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.624 1.569 . . . . 0.0 110.636 174.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -129.58 145.86 51.44 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 111.051 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.16 145.87 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 124.078 1.894 . . . . 0.0 110.749 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -147.84 100.28 3.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 111.465 -2.607 . . . . 0.0 106.499 -154.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.75 95.43 0.24 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 109.828 -176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? 27.55 59.19 0.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.464 2.706 . . . . 0.0 115.048 -163.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 66.71 -3.54 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.375 2.27 . . . . 0.0 115.692 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.66 -31.72 48.84 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.537 1.065 . . . . 0.0 114.148 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -162.51 153.14 17.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.618 1.567 . . . . 0.0 110.828 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -59.2 135.74 57.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.155 158.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.0 p -87.42 6.18 35.16 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.32 38.64 57.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.89 1.234 . . . . 0.0 112.893 -160.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.06 155.69 49.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.034 0.921 . . . . 0.0 111.847 162.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.33 169.45 14.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.302 1.841 . . . . 0.0 110.677 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 37.8 m-85 -145.0 137.09 25.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.17 108.11 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.843 1.657 . . . . 0.0 110.134 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.24 97.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.827 1.651 . . . . 0.0 110.711 159.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 13.3 mt -68.54 174.89 3.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.325 -0.86 . . . . 0.0 112.752 172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.8 -7.1 66.75 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 p -164.68 172.29 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.711 2.404 . . . . 0.0 109.681 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -75.49 -24.65 56.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 119.756 -1.84 . . . . 0.0 112.243 171.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.7 -30.45 71.55 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 120.524 1.511 . . . . 0.0 111.072 165.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.21 -48.62 79.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 117.531 -1.223 . . . . 0.0 112.023 161.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.3 m -52.5 -54.22 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 120.715 1.598 . . . . 0.0 111.895 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -55.26 -40.31 70.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.163 2.585 . . . . 0.0 114.837 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 47.3 mtm -62.96 -40.11 96.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.598 1.09 . . . . 0.0 112.496 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . . . -65.75 -34.58 78.5 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -24.45 67.74 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -53.92 -26.69 26.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.914 1.233 . . . . 0.0 112.802 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 7.1 mmmm -100.5 14.01 32.7 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.947 2.499 . . . . 0.0 112.718 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.287 51.5 p30 -70.69 10.79 0.45 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -165.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -150.77 45.67 0.85 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.6 1.96 . . . . 0.0 110.895 153.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -68.96 -170.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.674 1.19 . . . . 0.0 113.47 172.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -123.81 156.22 36.54 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.638 1.575 . . . . 0.0 112.459 154.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 14.9 tpt -146.33 146.45 30.69 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.075 1.35 . . . . 0.0 110.559 163.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.96 -81.83 0.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.379 1.466 . . . . 0.0 112.442 -171.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -156.55 19.66 0.34 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.152 1.781 . . . . 0.0 111.612 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.82 156.27 41.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.373 1.869 . . . . 0.0 110.157 -156.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -78.93 155.93 28.78 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.517 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.9 mm -138.33 82.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.53 1.132 . . . . 0.0 109.022 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -61.4 137.04 58.23 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.514 -0.741 . . . . 0.0 109.304 156.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.6 t -122.74 102.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.063 0.945 . . . . 0.0 109.919 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 60.4 m-85 -81.26 150.9 28.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.88 132.25 35.43 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.709 1.604 . . . . 0.0 106.74 155.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.32 179.93 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.823 0.849 . . . . 0.0 110.753 -160.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -134.2 144.14 48.28 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -65.6 -25.92 67.61 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.586 -1.321 . . . . 0.0 114.093 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -68.06 -40.99 82.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.178 0.991 . . . . 0.0 111.987 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.9 -48.78 75.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 110.491 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 96' ' ' VAL . 6.9 tmm? -55.82 -41.24 73.91 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.772 0.829 . . . . 0.0 112.988 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.57 -41.01 93.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.598 0.759 . . . . 0.0 112.043 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -54.01 44.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.337 1.455 . . . . 0.0 110.703 174.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 58' ' ' PHE . 27.0 m -73.95 -31.84 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -165.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 44' ' ' HIS . 7.9 mp -69.61 -15.71 63.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.916 1.286 . . . . 0.0 113.129 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.28 -52.64 2.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 126.318 1.847 . . . . 0.0 110.175 -174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.261 77.6 t60 40.66 45.93 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 129.677 3.191 . . . . 0.0 114.692 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -157.94 -2.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.802 1.641 . . . . 0.0 115.222 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 167.22 53.91 0.03 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 C--O 1.248 0.985 0 CA-C-N 122.441 3.121 . . . . 0.0 109.985 -14.367 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.4 -57.63 7.53 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -157.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.34 -30.54 22.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.093 2.957 . . . . 0.0 112.645 -14.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.93 -53.71 0.42 Allowed Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.496 1.522 . . . . 0.0 113.72 164.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.89 -22.04 22.71 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.678 3.585 . . . . 0.0 116.125 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.37 1.45 2.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.434 1.494 . . . . 0.0 114.525 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.91 -25.93 0.03 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.94 -45.71 1.98 Allowed Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 165.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.49 -26.26 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.79 159.87 24.63 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 122.156 0.865 . . . . 0.0 114.818 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -85.11 32.55 0.54 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.025 1.73 . . . . 0.0 113.843 -167.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.07 139.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.02 138.72 49.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.18 152.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 27.7 tttp -84.98 152.77 23.23 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 124.726 1.21 . . . . 0.0 108.262 167.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.95 120.11 18.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -128.12 118.72 23.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.492 0.663 . . . . 0.0 111.41 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.36 -25.36 2.88 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-N 114.6 -1.182 . . . . 0.0 114.39 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -39.76 156.43 0.15 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 128.929 2.892 . . . . 0.0 115.915 -169.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.11 145.2 99.16 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 121.772 1.648 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.11 27.71 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.534 1.133 . . . . 0.0 113.785 170.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -147.5 17.62 1.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.549 2.34 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -64.9 164.02 13.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.39 1.076 . . . . 0.0 111.288 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 98.8 p -151.22 172.64 15.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.508 1.147 . . . . 0.0 111.997 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 27' ' ' VAL . 53.0 t -49.52 -31.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 127.643 2.377 . . . . 0.0 115.022 172.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -77.85 -19.51 54.74 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.993 -1.067 . . . . 0.0 112.089 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 16.4 t0 -102.77 -16.15 16.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.496 1.918 . . . . 0.0 113.522 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -77.25 -45.24 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.46 -19.5 63.76 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.043 1.737 . . . . 0.0 114.716 170.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 50.2 t30 -75.4 -49.02 20.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.686 1.194 . . . . 0.0 111.533 165.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 78' ' ' MET . 37.1 t80 -57.11 -30.36 64.31 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.751 0.821 . . . . 0.0 112.984 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.96 43.89 2.97 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.811 1.644 . . . . 0.0 111.711 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -58.8 -14.21 8.19 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.135 164.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.02 -29.83 60.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.276 2.23 . . . . 0.0 113.599 162.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.29 158.39 39.91 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -137.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 131.63 54.0 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.844 1.657 . . . . 0.0 108.782 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.2 mp -107.55 159.5 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.193 1.397 . . . . 0.0 107.975 170.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 62' ' ' GLY 0.31 0.0 OUTLIER -86.24 6.56 29.04 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -168.634 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -145.07 -64.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.286 1.434 . . . . 0.0 110.88 157.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.83 -32.33 1.82 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 125.62 1.581 . . . . 0.0 113.42 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 43' ' ' VAL . . . -138.95 -25.56 0.87 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.606 1.162 . . . . 0.0 111.598 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.26 26.22 0.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.312 1.045 . . . . 0.0 111.775 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.69 19.54 0.78 Allowed Glycine 0 C--O 1.219 -0.817 0 C-N-CA 125.637 1.589 . . . . 0.0 109.295 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 24' ' ' VAL . 2.7 m -144.99 114.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 127.119 2.168 . . . . 0.0 107.315 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -132.25 87.74 2.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 123.411 1.577 . . . . 0.0 109.682 -156.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -66.76 137.63 56.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.852 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.34 144.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 122.913 1.339 . . . . 0.0 109.933 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -138.52 138.72 38.3 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.261 -160.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -117.4 33.49 5.6 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -122.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER 41.52 40.93 1.46 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.01 1.724 . . . . 0.0 113.96 -168.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -153.64 -18.68 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.64 1.576 . . . . 0.0 114.524 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.05 40.34 7.08 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.375 0.989 . . . . 0.0 112.672 -171.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -153.15 144.96 23.55 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.317 1.847 . . . . 0.0 109.428 -170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -81.26 144.9 31.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.093 0.949 . . . . 0.0 111.381 160.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.6 p -84.94 -12.12 54.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -162.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.99 31.06 78.32 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.559 -0.713 . . . . 0.0 113.132 -156.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.12 153.66 51.93 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.809 1.643 . . . . 0.0 110.2 166.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.28 173.08 16.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.824 1.65 . . . . 0.0 111.853 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.699 ' CE1' HG21 ' A' ' 96' ' ' VAL . 52.5 m-85 -139.25 151.16 46.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.532 1.933 . . . . 0.0 109.248 171.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 43' ' ' VAL . 74.0 t -149.55 108.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.41 -1.431 . . . . 0.0 110.751 -164.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.66 99.29 0.98 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.396 1.479 . . . . 0.0 110.648 169.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 67' ' ' VAL . 6.7 mt -73.79 167.49 21.31 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.052 -1.03 . . . . 0.0 113.358 176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -82.28 -8.08 86.83 Favored Glycine 0 CA--C 1.542 1.724 0 O-C-N 120.661 -1.275 . . . . 0.0 115.162 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.5 t -165.62 174.38 9.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.479 2.712 . . . . 0.0 108.632 166.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.74 -15.89 58.81 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 111.596 167.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.0 -49.99 70.14 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.508 156.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.11 -40.22 92.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 117.666 -1.159 . . . . 0.0 111.898 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.549 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.7 m -57.05 -50.53 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 120.689 1.586 . . . . 0.0 112.111 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -47.6 63.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.566 1.946 . . . . 0.0 112.426 173.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mtm -62.82 -31.87 72.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.622 1.169 . . . . 0.0 112.436 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.98 58.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.071 0.949 . . . . 0.0 113.485 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.01 -27.21 66.69 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.849 -1.157 . . . . 0.0 113.232 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -51.65 -30.81 23.07 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.457 1.026 . . . . 0.0 113.062 170.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 27.0 mmtp -95.95 6.9 47.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.994 1.718 . . . . 0.0 114.585 -176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.2 p-10 -61.19 8.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 119.408 3.114 . . . . 0.0 119.408 -161.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 10.25 0.2 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 129.037 2.935 . . . . 0.0 114.126 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.296 9.4 pt-20 -93.99 -166.96 1.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.846 0.748 . . . . 0.0 112.049 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -143.77 152.4 41.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.359 1.464 . . . . 0.0 114.06 -155.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 2.7 tpt -151.93 147.14 26.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.198 1.799 . . . . 0.0 110.982 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.96 33.23 82.99 Favored Glycine 0 CA--C 1.541 1.681 0 O-C-N 121.61 -0.681 . . . . 0.0 113.455 -167.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 56.54 32.06 20.15 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 114.112 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -147.28 153.72 40.09 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.35 150.1 23.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mm -133.03 83.12 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.12 0.968 . . . . 0.0 109.264 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -66.92 114.56 5.84 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.923 -1.111 . . . . 0.0 109.306 168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 17.7 t -95.76 111.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 58.1 m-85 -96.67 148.99 22.3 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.035 0.934 . . . . 0.0 109.975 172.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.1 129.94 37.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.75 2.02 . . . . 0.0 106.849 163.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -146.31 172.63 13.19 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.003 1.321 . . . . 0.0 110.559 -165.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -133.78 162.42 32.03 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.152 -0.967 . . . . 0.0 112.103 -167.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -66.87 -45.2 78.82 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 p -53.45 -49.1 68.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.707 1.203 . . . . 0.0 111.926 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.61 -49.21 74.19 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.937 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 96' ' ' VAL . 7.1 tmm? -61.32 -38.67 87.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.618 1.167 . . . . 0.0 113.526 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.65 -34.63 78.67 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.526 -0.734 . . . . 0.0 112.098 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -55.38 18.77 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.521 1.528 . . . . 0.0 110.483 171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.699 HG21 ' CE1' ' A' ' 58' ' ' PHE . 31.8 m -71.72 -34.82 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -166.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.87 -14.64 62.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -39.59 28.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.563 1.145 . . . . 0.0 110.561 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -71.39 45.79 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 129.06 2.944 . . . . 0.0 112.926 169.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 m -152.22 178.82 9.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.455 1.502 . . . . 0.0 112.62 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.81 -155.36 7.25 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.703 1.62 . . . . 0.0 111.95 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.693 2.929 . . . . 0.0 112.273 167.223 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 tpt 60.45 -48.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.71 2.404 . . . . 0.0 115.277 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.3 tp -150.09 -16.4 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 114.888 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.45 29.65 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.356 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -87.53 -15.98 26.66 Favored 'Cis proline' 0 CA--C 1.542 0.909 0 CA-C-N 120.092 1.946 . . . . 0.0 113.943 -1.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -27.87 69.13 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.93 -2.62 0.21 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.612 -1.66 . . . . 0.0 117.223 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.99 -173.85 25.94 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 120.995 2.398 . . . . 0.0 116.565 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -45.0 8.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.236 174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.45 -154.35 24.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.823 0.725 . . . . 0.0 113.059 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -124.09 38.72 4.13 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.606 1.962 . . . . 0.0 110.441 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.86 140.07 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.81 0.814 . . . . 0.0 110.036 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.48 139.1 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.283 154.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 33.4 tttp -80.59 153.87 27.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 164.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HB3' HD21 ' A' ' 18' ' ' LEU . 2.6 mp -118.98 152.38 36.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.907 0.861 . . . . 0.0 112.816 155.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -142.04 139.14 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.267 164.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.87 -30.35 4.42 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.423 1.487 . . . . 0.0 114.376 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 15' ' ' LEU . 1.2 mt -36.71 145.52 0.25 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 128.293 2.637 . . . . 0.0 115.328 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -74.16 166.27 29.96 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.274 2.649 . . . . 0.0 113.327 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -64.46 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.784 2.433 . . . . 0.0 114.598 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -131.24 -2.5 3.94 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.944 2.098 . . . . 0.0 112.605 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.25 140.71 56.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.631 0.729 . . . . 0.0 111.413 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.6 p -148.37 173.26 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.22 2.208 . . . . 0.0 109.909 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.752 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.3 t -40.02 -35.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 165.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -77.0 -22.7 52.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 120.243 -1.536 . . . . 0.0 111.314 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 15.8 t0 -96.39 -20.29 18.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.0 2.12 . . . . 0.0 114.01 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 p -79.28 -43.1 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -65.09 -42.2 94.3 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.927 1.691 . . . . 0.0 112.612 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 15.2 t30 -56.79 -52.15 66.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.788 1.631 . . . . 0.0 112.535 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 83' ' ' ILE . 15.0 t80 -50.76 -31.57 17.15 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.892 1.677 . . . . 0.0 113.189 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -122.11 8.36 9.79 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -169.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 p -40.36 -9.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 1 N-CA-C 122.368 4.21 . . . . 0.0 122.368 -157.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -29.78 68.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 152.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.5 p -76.37 154.31 35.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 114.045 -163.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 m -91.19 -47.32 7.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.531 0.733 . . . . 0.0 112.704 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp 50.28 162.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.176 1.791 . . . . 0.0 111.077 -150.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 26.54 0.05 OUTLIER 'General case' 0 CA--C 1.564 1.486 0 O-C-N 118.593 -2.567 . . . . 0.0 113.797 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 173.14 -54.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.994 3.318 . . . . 0.0 109.727 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.61 -42.11 1.18 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.466 1.984 . . . . 0.0 112.782 -174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.3 -30.9 2.35 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.978 2.111 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.85 19.5 0.52 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.6 -9.25 2.62 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 124.023 0.821 . . . . 0.0 111.267 166.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.752 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.3 m -92.92 149.54 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 119.299 1.55 . . . . 0.0 110.891 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -149.24 145.72 27.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.225 1.81 . . . . 0.0 107.912 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.52 0.728 . . . . 0.0 109.415 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -108.1 154.05 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 124.905 2.288 . . . . 0.0 111.906 -174.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.625 ' H ' HG22 ' A' ' 46' ' ' ILE . 39.2 m-85 -160.24 138.86 10.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 129.455 3.102 . . . . 0.0 104.713 -151.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.3 p -110.48 14.27 22.56 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -160.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -116.92 -149.7 0.45 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 116.555 -3.841 . . . . 0.0 113.233 38.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 0.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -156.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -109.93 1.08 30.15 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.668 1.604 . . . . 0.0 115.272 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -146.48 77.77 1.49 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.652 1.226 . . . . 0.0 112.387 -160.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -52.53 124.51 13.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.454 1.501 . . . . 0.0 112.745 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.1 p -82.4 -5.23 58.51 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.99 91.4 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.17 1.367 . . . . 0.0 112.98 -167.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -140.87 168.1 20.6 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.46 1.104 . . . . 0.0 110.027 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.36 177.38 11.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.105 0.962 . . . . 0.0 111.999 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 44.7 m-85 -143.54 144.6 32.02 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.884 1.674 . . . . 0.0 108.848 166.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.1 t -145.97 107.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.205 -1.56 . . . . 0.0 109.403 -167.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.95 97.02 0.05 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.033 1.333 . . . . 0.0 110.56 161.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 67' ' ' VAL . 2.1 mt -67.34 167.52 12.33 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.928 0.87 . . . . 0.0 112.214 172.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.65 -1.13 64.02 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 114.612 -170.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.6 p -162.34 171.44 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.975 2.51 . . . . 0.0 108.898 160.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -74.41 -16.25 60.89 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 119.776 -1.828 . . . . 0.0 112.544 169.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.4 -32.13 66.11 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.808 -1.808 . . . . 0.0 110.478 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB3' HD22 ' A' ' 61' ' ' LEU . 18.0 m-20 -61.68 -38.26 87.15 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.877 162.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.756 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.5 m -57.85 -48.3 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.839 1.654 . . . . 0.0 111.623 171.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -55.24 -40.29 70.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 113.331 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mmt -57.73 -38.94 76.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 121.201 1.819 . . . . 0.0 112.297 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -72.13 -38.66 69.21 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.77 -25.71 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -52.51 -25.73 11.12 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.325 1.42 . . . . 0.0 113.391 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -116.71 21.93 13.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.764 2.426 . . . . 0.0 111.912 -169.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.75 0.87 0.17 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.48 35.06 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.099 2.56 . . . . 0.0 111.767 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -171.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.522 1.929 . . . . 0.0 113.878 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 164.96 14.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.809 1.643 . . . . 0.0 111.324 148.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -14.87 11.86 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.45 -0.781 . . . . 0.0 112.803 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.58 112.97 0.43 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.339 1.924 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 42.7 m80 59.8 -7.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.356 2.262 . . . . 0.0 117.093 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -151.39 155.38 38.52 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.288 1.835 . . . . 0.0 112.15 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -91.04 157.88 17.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 123.015 1.388 . . . . 0.0 113.322 -168.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 30' ' ' PHE . 5.3 mm -140.37 76.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 124.735 1.214 . . . . 0.0 108.834 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -68.56 130.61 43.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 164.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -117.74 123.93 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 108.485 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.8 m-85 -109.65 148.86 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.178 0.991 . . . . 0.0 109.441 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -77.15 146.89 36.84 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.539 0.736 . . . . 0.0 109.205 162.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -155.66 176.43 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.853 0.861 . . . . 0.0 110.434 -158.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.33 141.73 49.06 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.682 -0.636 . . . . 0.0 111.161 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -35.36 73.18 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.975 1.31 . . . . 0.0 112.838 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.8 m -69.44 -50.0 49.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.988 1.715 . . . . 0.0 112.371 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -70.51 -36.54 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 96' ' ' VAL . 9.5 tmm? -54.12 -36.54 63.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.221 1.009 . . . . 0.0 113.463 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.72 -36.6 83.51 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.508 -0.745 . . . . 0.0 112.694 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -53.11 18.1 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.737 1.615 . . . . 0.0 110.832 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 25.9 m -69.62 -24.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -165.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.05 -10.3 59.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.698 1.599 . . . . 0.0 114.209 170.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -145.38 60.13 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 110.44 -151.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.48 -6.42 4.2 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -140.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.6 t -161.06 -18.06 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.0 66.58 0.01 OUTLIER Glycine 0 CA--C 1.541 1.685 0 CA-C-O 117.913 -1.493 . . . . 0.0 114.575 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 C--O 1.247 0.937 0 CA-C-N 120.815 2.307 . . . . 0.0 111.103 2.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.7 mtp -137.63 -11.3 1.59 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.9 -7.18 5.54 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 -163.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.86 -79.5 0.37 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.909 -0.939 . . . . 0.0 113.981 158.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 -21.1 30.12 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.184 2.59 . . . . 0.0 111.06 161.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -76.75 75.34 3.4 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 148.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -0.13 105.56 0.01 OUTLIER Glycine 0 N--CA 1.478 1.494 1 C-N-CA 131.231 4.253 . . . . 0.0 118.366 -169.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.7 1.19 21.7 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.209 1.385 . . . . 0.0 116.155 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 -20.81 4.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.186 1.493 . . . . 0.0 113.924 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.02 -168.68 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.46 1.505 . . . . 0.0 112.052 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -123.46 36.33 4.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 112.476 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.4 140.0 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.958 0.885 . . . . 0.0 111.099 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -122.63 133.01 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.3 155.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 14.6 tttp -74.55 144.39 44.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.384 1.474 . . . . 0.0 107.747 167.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 115.84 16.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 126.779 2.032 . . . . 0.0 108.334 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.86 127.94 19.63 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.878 0.871 . . . . 0.0 110.224 -158.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.29 -23.36 8.58 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.595 1.093 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.78 159.43 0.23 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 130.92 3.688 . . . . 0.0 115.158 -169.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.31 143.14 34.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.225 2.617 . . . . 0.0 114.394 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -65.93 0.26 1.93 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 114.715 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -144.58 44.64 1.39 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.84 1.256 . . . . 0.0 112.471 161.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -59.1 161.59 5.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.304 1.441 . . . . 0.0 113.038 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.1 p -137.6 171.3 14.66 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.811 1.291 . . . . 0.0 112.591 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 43' ' ' VAL . 11.2 t -40.44 -52.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 157.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.02 -26.22 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.089 -1.632 . . . . 0.0 110.267 -164.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.82 -43.99 94.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.23 3.012 . . . . 0.0 113.378 164.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -73.68 -37.59 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 109.851 -172.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.45 -21.84 22.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.316 1.446 . . . . 0.0 114.057 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -67.17 -50.0 62.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.765 1.626 . . . . 0.0 112.585 160.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 83' ' ' ILE . 29.4 t80 -56.93 -30.31 63.88 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.273 1.029 . . . . 0.0 111.794 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 mt -121.66 45.35 2.33 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 112.908 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.42 -14.3 18.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.603 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -26.51 65.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.39 2.276 . . . . 0.0 113.625 164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -126.42 151.65 47.41 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -141.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 120.84 36.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.224 1.01 . . . . 0.0 109.33 171.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.9 mm -87.55 161.25 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 158.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . 0.25 0.3 OUTLIER -67.3 -3.04 6.94 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.14 -55.14 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.315 1.846 . . . . 0.0 111.339 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.01 -36.97 1.46 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.351 1.453 . . . . 0.0 113.214 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.78 -26.66 1.55 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.245 1.818 . . . . 0.0 110.945 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.95 18.0 1.1 Allowed 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.093 -1.004 . . . . 0.0 113.567 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.86 -12.87 3.49 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.339 0.971 . . . . 0.0 111.301 165.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.5 m -92.94 154.36 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 C-N-CA 126.125 1.77 . . . . 0.0 111.341 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.42 ' CB ' HD21 ' A' ' 97' ' ' LEU . 5.2 m80 -152.6 142.23 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.089 1.355 . . . . 0.0 108.841 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -120.22 139.54 52.51 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.316 0.646 . . . . 0.0 109.581 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.43 141.17 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 122.471 1.129 . . . . 0.0 108.575 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.8 110.27 7.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.447 -1.706 . . . . 0.0 107.517 -155.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -66.84 178.98 1.18 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.134 0.974 . . . . 0.0 111.909 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -24.25 54.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.841 0.857 . . . . 0.0 113.156 169.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.35 -10.39 59.54 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.388 1.075 . . . . 0.0 113.538 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.58 41.69 28.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.216 -0.927 . . . . 0.0 112.542 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -150.96 149.02 29.1 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.802 1.641 . . . . 0.0 110.999 -160.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -66.95 123.46 20.27 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.079 -1.013 . . . . 0.0 113.434 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -74.16 11.28 0.96 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.086 1.754 . . . . 0.0 115.089 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.5 26.81 46.37 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 125.106 1.336 . . . . 0.0 113.638 -162.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -139.66 151.95 46.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.71 1.604 . . . . 0.0 110.862 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.55 172.51 15.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.357 2.263 . . . . 0.0 109.426 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 45.9 m-85 -147.86 144.96 28.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.53 1.532 . . . . 0.0 108.631 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -143.75 108.34 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.062 -1.649 . . . . 0.0 110.258 -169.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.79 104.12 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.634 1.561 . . . . 0.0 110.797 156.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 8.4 mt -68.08 175.58 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.075 166.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.01 -4.38 61.47 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.23 0.919 . . . . 0.0 114.961 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.9 p -162.6 172.23 15.71 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.39 2.276 . . . . 0.0 109.452 161.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -75.46 -19.47 59.41 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.794 -1.817 . . . . 0.0 112.473 171.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.53 -29.44 67.05 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.533 -1.354 . . . . 0.0 110.657 167.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -63.91 -43.51 95.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.523 161.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 64' ' ' GLU . 5.2 m -54.21 -51.24 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.956 1.707 . . . . 0.0 111.947 174.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -55.0 -42.72 72.86 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.228 2.611 . . . . 0.0 113.839 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.7 mmt -61.32 -27.21 68.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.213 1.005 . . . . 0.0 113.15 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -86.72 -33.46 20.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.13 0.972 . . . . 0.0 112.645 174.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.59 -29.46 70.47 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.753 -1.217 . . . . 0.0 113.305 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -62.95 -15.32 55.36 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.859 -1.15 . . . . 0.0 113.963 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -105.17 13.64 30.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.27 2.228 . . . . 0.0 112.956 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.99 9.06 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -165.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -153.99 30.61 0.45 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.266 1.426 . . . . 0.0 113.866 168.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.47 -171.66 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.919 1.688 . . . . 0.0 113.861 173.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.2 p -128.31 153.43 47.0 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.149 1.78 . . . . 0.0 112.576 163.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.43 115.45 5.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.867 1.667 . . . . 0.0 107.767 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.6 -168.59 53.8 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.776 0.703 . . . . 0.0 112.198 -157.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -72.47 30.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.583 1.553 . . . . 0.0 113.038 172.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -148.67 147.3 28.76 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.41 2.284 . . . . 0.0 110.737 -155.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -90.48 150.09 21.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.252 1.025 . . . . 0.0 112.108 -172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 30' ' ' PHE . 7.5 mm -131.54 76.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.48 141.08 58.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.401 160.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 70' ' ' ALA . 4.3 t -127.78 92.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.919 0.866 . . . . 0.0 109.68 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 61.2 m-85 -85.06 145.35 27.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.819 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.09 143.24 55.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.3 m -152.44 165.53 34.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.253 0.621 . . . . 0.0 110.064 -169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.99 147.33 49.68 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.051 0.94 . . . . 0.0 108.858 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -59.18 -33.93 71.53 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.097 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -56.08 8.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.386 1.448 . . . . 0.0 114.761 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -78.84 -27.86 44.28 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.642 0.258 . . . . 0.0 111.136 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -65.44 -43.4 90.58 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.012 0.91 . . . . 0.0 113.06 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.61 -29.22 70.45 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.142 1.377 . . . . 0.0 111.33 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -61.58 1.88 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.628 2.371 . . . . 0.0 111.893 168.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 29.0 m -65.77 -24.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -161.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD21 ' CB ' ' A' ' 44' ' ' HIS . 8.0 mp -67.95 -18.45 64.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.776 2.03 . . . . 0.0 115.164 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -145.05 48.24 1.3 Allowed 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 123.824 1.773 . . . . 0.0 108.731 -141.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -81.65 13.93 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.733 -136.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.1 p -142.88 11.23 1.81 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.303 2.241 . . . . 0.0 113.808 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.69 169.34 32.34 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 116.177 1.231 . . . . 0.0 116.177 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.252 1.198 1 C-N-CA 125.37 4.047 . . . . 0.0 114.085 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt 138.94 -18.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 1 C-N-CA 132.188 4.195 . . . . 0.0 110.639 -164.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.12 172.71 12.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.318 1.847 . . . . 0.0 113.173 -160.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.74 -33.41 1.58 Allowed Glycine 0 CA--C 1.547 2.045 0 N-CA-C 119.311 2.485 . . . . 0.0 119.311 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.37 -11.69 3.26 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.144 3.229 . . . . 0.0 117.055 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.01 161.25 32.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.683 1.593 . . . . 0.0 112.209 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.01 109.42 0.8 Allowed Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.882 1.23 . . . . 0.0 113.355 -170.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.07 39.15 1.47 Allowed Glycine 0 CA--C 1.532 1.109 0 O-C-N 119.11 -2.406 . . . . 0.0 113.446 -21.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -128.96 3.66 5.33 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.614 2.366 . . . . 0.0 114.631 23.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.53 60.6 0.1 Allowed Glycine 0 N--CA 1.47 0.945 0 O-C-N 121.066 -1.021 . . . . 0.0 114.63 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.27 45.75 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.744 2.018 . . . . 0.0 114.625 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.64 146.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 122.482 1.134 . . . . 0.0 111.27 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.28 136.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.968 151.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 12.7 tttp -81.34 153.19 27.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.176 1.391 . . . . 0.0 108.123 165.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -137.22 124.96 22.41 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.178 1.791 . . . . 0.0 106.981 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -134.88 123.68 23.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.277 0.561 . . . . 0.0 111.969 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.53 -19.51 4.25 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.416 1.008 . . . . 0.0 114.209 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -42.17 159.51 0.19 Allowed Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 128.807 2.843 . . . . 0.0 117.123 -166.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -52.06 6.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.082 1 C-N-CA 127.507 5.471 . . . . 0.0 120.032 177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 69.12 -27.92 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.167 2.587 . . . . 0.0 115.47 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -114.82 20.63 15.03 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.16 154.96 7.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.782 1.633 . . . . 0.0 111.413 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 81.2 p -144.66 169.4 18.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 0.0 113.137 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG13 HG21 ' A' ' 43' ' ' VAL . 3.5 t -38.64 -33.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 128.516 2.726 . . . . 0.0 117.458 164.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -78.55 -30.25 46.8 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.463 -1.398 . . . . 0.0 111.179 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 14.3 t0 -89.13 -13.86 37.5 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.418 2.287 . . . . 0.0 114.169 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 24' ' ' VAL . 13.1 p -86.76 -52.11 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -56.58 -26.72 56.14 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.795 -1.19 . . . . 0.0 113.64 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.2 t30 -72.7 -43.16 63.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.122 1.769 . . . . 0.0 113.815 168.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 31' ' ' LEU . 49.5 t80 -75.22 -33.84 61.39 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.684 1.129 . . . . 0.0 109.172 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 30' ' ' PHE . 1.5 mm? -101.04 33.98 2.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.191 2.596 . . . . 0.0 110.063 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -11.83 47.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.648 0.779 . . . . 0.0 112.504 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.67 -18.16 39.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 113.683 161.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.36 152.27 44.23 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 -139.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.25 125.56 44.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.677 1.191 . . . . 0.0 109.781 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -97.97 150.94 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 165.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -64.61 10.3 0.07 Allowed 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 36' ' ' ILE . 5.9 t70 -168.13 -59.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.022 2.129 . . . . 0.0 109.7 165.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.67 -39.72 1.2 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.47 1.986 . . . . 0.0 112.738 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.5 -30.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.468 1.507 . . . . 0.0 111.021 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.88 23.17 0.46 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.981 0.912 . . . . 0.0 111.895 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.52 23.3 1.2 Allowed Glycine 0 C--O 1.218 -0.882 0 C-N-CA 125.842 1.687 . . . . 0.0 109.013 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.67 HG21 HG13 ' A' ' 24' ' ' VAL . 3.3 m -135.04 150.39 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.91 1.684 . . . . 0.0 109.404 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.465 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 m80 -152.43 144.65 23.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.977 1.311 . . . . 0.0 108.614 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.11 134.12 51.44 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.305 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.49 157.3 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 124.8 2.238 . . . . 0.0 110.456 -165.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -137.94 146.01 42.72 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.209 3.004 . . . . 0.0 106.159 -165.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -125.87 46.88 2.32 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -160.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -0.06 2.77 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 117.276 -3.39 . . . . 0.0 113.922 16.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.76 -28.97 2.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -153.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.74 28.16 0.25 Allowed Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.683 1.135 . . . . 0.0 113.948 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -158.91 120.15 3.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.076 1.35 . . . . 0.0 111.011 -162.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -61.31 165.38 4.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.261 172.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 p -134.57 168.91 18.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.403 1.481 . . . . 0.0 110.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.83 43.28 2.79 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 121.257 -0.902 . . . . 0.0 112.592 168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -138.65 154.71 48.65 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.402 1.096 . . . . 0.0 113.307 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.18 169.06 24.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.302 1.841 . . . . 0.0 110.873 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 35.4 m-85 -144.83 143.94 30.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.897 1.679 . . . . 0.0 108.446 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 27' ' ' VAL . 42.8 t -146.56 110.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.371 -1.455 . . . . 0.0 110.234 -165.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -61.13 102.69 0.22 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.414 1.006 . . . . 0.0 111.478 161.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.2 mp -68.0 170.98 7.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.276 1.036 . . . . 0.0 112.853 166.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.71 -4.17 67.89 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.564 1.078 . . . . 0.0 114.64 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -161.67 169.79 20.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.679 1.992 . . . . 0.0 110.759 160.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 67' ' ' VAL . 8.7 tt0 -75.02 -14.4 60.6 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.85 -1.781 . . . . 0.0 112.019 170.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -70.48 -37.1 74.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 119.467 -2.021 . . . . 0.0 110.201 164.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.83 -42.32 88.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.159 0.984 . . . . 0.0 112.505 163.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.664 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.1 m -57.01 -50.5 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.998 1.726 . . . . 0.0 111.793 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -43.63 73.45 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.247 1.819 . . . . 0.0 113.741 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.5 mtm -63.95 -35.19 79.87 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.85 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.94 -35.79 69.71 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.343 0.657 . . . . 0.0 112.38 169.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.24 -26.77 68.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.17 -1.582 . . . . 0.0 113.856 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -49.67 -31.25 10.63 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.842 1.201 . . . . 0.0 112.622 169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -98.47 9.5 43.01 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.504 1.922 . . . . 0.0 113.428 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 1.3 p-10 -63.86 8.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.79 14.99 0.36 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.359 1.864 . . . . 0.0 114.401 167.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.275 8.0 pt-20 -79.53 -162.89 0.45 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.563 0.62 . . . . 0.0 111.601 166.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -145.89 160.32 41.97 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.603 -1.311 . . . . 0.0 113.662 -161.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 tpt -150.0 84.09 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.357 1.063 . . . . 0.0 112.422 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.29 1.38 7.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.697 3.046 . . . . 0.0 113.385 -5.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -126.14 4.9 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.654 1.982 . . . . 0.0 111.676 171.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.81 149.57 38.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 128.444 2.697 . . . . 0.0 109.985 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -84.3 154.39 22.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.921 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 mm -132.02 77.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.857 0.837 . . . . 0.0 108.861 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -67.3 112.54 4.6 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.359 -0.838 . . . . 0.0 110.258 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 16.6 t -94.85 102.77 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.706 0.802 . . . . 0.0 109.311 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 55.7 m-85 -88.18 148.62 24.31 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.051 -1.031 . . . . 0.0 109.216 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -72.59 139.03 47.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 161.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -149.22 167.6 25.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.484 1.514 . . . . 0.0 109.163 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -144.88 167.89 21.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.273 -0.892 . . . . 0.0 112.757 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -67.0 47.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.739 2.816 . . . . 0.0 114.078 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.8 m -157.84 -53.61 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.259 2.224 . . . . 0.0 108.521 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -70.37 -42.24 72.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 111.139 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -62.21 -41.81 98.72 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.298 1.047 . . . . 0.0 112.304 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.12 -32.91 74.65 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.47 -0.769 . . . . 0.0 111.875 -175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -55.6 25.54 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.805 1.642 . . . . 0.0 111.026 168.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 30.9 m -70.61 -25.82 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -164.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD12 HG23 ' A' ' 96' ' ' VAL . 11.0 mp -77.12 -3.86 41.51 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.42 1.088 . . . . 0.0 113.176 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -120.49 8.27 10.72 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.831 2.452 . . . . 0.0 111.649 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -57.95 -18.17 21.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 129.401 3.08 . . . . 0.0 114.585 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -58.43 93.59 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.039 1.736 . . . . 0.0 112.438 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.11 63.68 0.06 OUTLIER Glycine 0 CA--C 1.541 1.702 0 C-N-CA 125.348 1.452 . . . . 0.0 114.177 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.249 1.073 0 CA-C-N 120.222 2.011 . . . . 0.0 113.396 1.559 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.0 mmt -59.57 -26.77 65.68 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.689 1.196 . . . . 0.0 112.545 169.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -131.58 160.98 33.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.825 2.05 . . . . 0.0 111.44 159.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 20.49 67.07 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 128.353 2.882 . . . . 0.0 118.641 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.63 151.14 86.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.718 2.946 . . . . 0.0 113.79 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.64 -34.4 0.92 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.72 -43.75 0.03 OUTLIER Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.912 1.233 . . . . 0.0 115.036 -176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.37 -18.9 0.27 Allowed Glycine 0 CA--C 1.544 1.885 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -61.45 -24.51 66.6 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.579 2.19 . . . . 0.0 113.784 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.45 178.77 38.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.756 2.122 . . . . 0.0 109.148 168.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -117.25 31.55 6.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.229 1.412 . . . . 0.0 110.39 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.64 134.43 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.648 0.737 . . . . 0.0 109.857 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.69 129.25 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.153 153.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 23.1 tttp -79.36 144.32 34.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -132.98 113.67 13.1 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 126.519 1.928 . . . . 0.0 106.241 -168.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.09 138.12 48.01 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.616 1.167 . . . . 0.0 110.509 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.35 -30.08 7.22 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.155 0.883 . . . . 0.0 113.267 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -39.22 155.85 0.14 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 130.637 3.575 . . . . 0.0 116.102 -172.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -58.68 141.44 97.65 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.693 2.262 . . . . 0.0 112.394 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -64.61 1.95 0.74 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.321 1.849 . . . . 0.0 114.483 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.9 p -125.08 7.69 7.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.645 1.978 . . . . 0.0 112.712 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.8 t -58.81 152.52 18.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 112.525 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -148.68 164.62 33.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.027 1.731 . . . . 0.0 111.356 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.673 ' HB ' HG21 ' A' ' 43' ' ' VAL 0.287 0.3 OUTLIER -54.37 -18.4 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 177.695 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.57 -31.52 70.78 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.406 -2.058 . . . . 0.0 110.679 169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.49 -18.36 38.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.661 1.985 . . . . 0.0 113.723 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 24' ' ' VAL . 11.4 m -71.81 -44.92 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 123.319 1.533 . . . . 0.0 107.989 174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.11 -35.35 74.07 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.387 3.075 . . . . 0.0 114.065 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.22 -32.75 29.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.315 0.961 . . . . 0.0 112.548 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 83' ' ' ILE . 21.7 t80 -58.38 -37.54 75.48 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.231 -0.918 . . . . 0.0 111.342 163.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.35 48.7 0.97 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 123.526 1.631 . . . . 0.0 113.107 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.4 p -62.16 46.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 129.611 3.164 . . . . 0.0 111.933 155.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.44 -20.25 0.08 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 130.666 3.586 . . . . 0.0 112.405 -159.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 t -149.03 172.34 14.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.659 0.784 . . . . 0.0 112.696 -148.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.88 121.09 34.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 109.414 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mp -85.12 152.93 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 154.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 6.6 t60 -64.66 13.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -168.56 -49.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.038 2.935 . . . . 0.0 109.475 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.78 -44.48 1.07 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 126.818 2.151 . . . . 0.0 111.628 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.13 -11.73 3.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.693 1.197 . . . . 0.0 113.583 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.28 4.12 3.99 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.73 -10.86 6.21 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.188 0.899 . . . . 0.0 114.252 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.673 HG21 ' HB ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -89.36 144.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 122.653 1.216 . . . . 0.0 111.247 -172.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.02 157.14 46.13 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.586 2.354 . . . . 0.0 109.511 167.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -118.37 156.14 29.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.936 0.894 . . . . 0.0 110.092 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 97' ' ' LEU . 14.0 mm -95.56 148.18 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 CA-C-O 123.799 1.761 . . . . 0.0 108.267 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -138.46 151.81 47.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 110.633 -2.985 . . . . 0.0 105.894 -154.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.81 -21.24 48.01 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -150.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -111.7 152.69 27.44 Favored 'General case' 0 N--CA 1.48 1.04 2 C-N-CA 132.367 4.267 . . . . 0.0 110.017 -17.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -81.28 -177.61 6.55 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.888 2.475 . . . . 0.0 110.154 -21.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.7 -58.1 0.57 Allowed Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.117 0.865 . . . . 0.0 113.935 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -155.52 169.14 24.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.291 1.437 . . . . 0.0 111.03 -170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -66.89 166.43 13.45 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.51 0.671 . . . . 0.0 111.606 169.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 t -123.68 176.64 6.12 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.905 1.682 . . . . 0.0 109.406 167.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.05 34.18 1.71 Allowed Glycine 0 N--CA 1.475 1.247 0 O-C-N 121.017 -1.052 . . . . 0.0 114.105 175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -134.03 154.53 51.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.448 1.118 . . . . 0.0 112.127 161.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.14 170.84 20.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.159 2.184 . . . . 0.0 109.955 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 50.6 m-85 -149.83 135.57 18.52 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.304 1.042 . . . . 0.0 110.386 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 ' HB ' ' A' ' 43' ' ' VAL . 58.1 t -141.98 105.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.694 1.198 . . . . 0.0 111.918 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.22 100.48 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.102 1.361 . . . . 0.0 110.838 162.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 13.9 mt -67.29 179.63 1.2 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.221 1.008 . . . . 0.0 113.133 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -92.57 -12.02 58.73 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.548 1.071 . . . . 0.0 115.725 -174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t -159.53 172.76 17.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 108.571 161.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.606 ' HA ' HG13 ' A' ' 67' ' ' VAL . 14.9 tt0 -71.13 -23.24 62.05 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.154 -1.591 . . . . 0.0 111.243 170.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.42 -37.42 80.8 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.314 -1.491 . . . . 0.0 111.006 168.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.58 -42.38 98.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.455 1.102 . . . . 0.0 112.209 165.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.2 m -55.57 -49.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.612 1.551 . . . . 0.0 111.742 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -52.72 -45.96 67.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.49 2.716 . . . . 0.0 113.583 169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.5 mmt -61.78 -38.66 88.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.101 0.864 . . . . 0.0 112.129 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.78 -31.02 67.66 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.559 -0.713 . . . . 0.0 112.227 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.47 -27.93 69.62 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -51.53 -27.85 12.0 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.502 1.046 . . . . 0.0 113.051 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -105.43 13.38 30.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.605 2.362 . . . . 0.0 113.148 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.63 11.77 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 119.221 3.045 . . . . 0.0 119.221 -165.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 34.66 0.2 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.459 1.904 . . . . 0.0 112.105 165.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.07 -173.79 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.809 1.643 . . . . 0.0 113.251 170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.1 p -127.54 152.15 47.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.684 1.194 . . . . 0.0 112.118 154.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.1 tpt -151.5 153.54 34.8 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.199 1.399 . . . . 0.0 111.046 170.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.09 -79.69 0.39 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.848 1.213 . . . . 0.0 111.123 -166.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -156.34 15.11 0.32 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.736 1.615 . . . . 0.0 112.894 166.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -140.01 156.91 46.4 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.835 2.054 . . . . 0.0 111.819 -158.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.49 146.15 53.41 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.831 0.824 . . . . 0.0 112.229 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.451 HG21 ' CE2' ' A' ' 30' ' ' PHE . 8.7 mm -131.5 76.71 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.369 1.081 . . . . 0.0 108.977 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -65.04 134.7 54.42 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.618 -0.676 . . . . 0.0 110.015 162.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.98 101.26 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.9 0.88 . . . . 0.0 109.474 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 67.0 m-85 -85.82 141.13 29.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.993 0.901 . . . . 0.0 108.954 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -66.54 130.49 43.36 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 159.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -142.87 169.71 17.06 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.448 0.299 . . . . 0.0 110.8 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -134.12 158.49 43.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.244 0.618 . . . . 0.0 111.204 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -72.78 45.2 0.14 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.491 2.316 . . . . 0.0 112.907 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -146.62 -52.69 0.23 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.191 2.196 . . . . 0.0 109.943 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.01 -49.57 75.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.685 0.794 . . . . 0.0 109.313 160.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.432 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.4 tmm? -58.93 -42.68 90.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.308 1.051 . . . . 0.0 113.101 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 -33.94 77.0 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.824 -1.172 . . . . 0.0 112.314 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -58.96 5.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.62 1.568 . . . . 0.0 110.233 168.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 27.6 m -69.31 -28.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -163.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 HG23 ' A' ' 96' ' ' VAL . 8.8 mp -68.67 -11.24 59.92 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.245 0.93 . . . . 0.0 113.125 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -98.56 -18.81 17.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.376 1.47 . . . . 0.0 113.034 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -53.8 135.7 41.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.84 2.056 . . . . 0.0 114.028 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.49 -34.66 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.969 1.308 . . . . 0.0 112.348 162.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.85 80.42 0.03 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.853 2.168 . . . . 0.0 111.829 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.253 1.23 0 CA-C-N 120.925 2.362 . . . . 0.0 116.469 0.823 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 tmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.5 mmt 59.77 24.4 13.35 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.708 2.003 . . . . 0.0 116.323 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pp -149.01 173.13 13.69 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.896 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 174.47 12.85 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.598 1.57 . . . . 0.0 115.401 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.84 -4.23 58.02 Favored 'Cis proline' 0 CA--C 1.546 1.079 0 CA-C-N 118.553 1.177 . . . . 0.0 114.651 3.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -61.76 -43.73 98.29 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 -2.35 0.19 Allowed Glycine 0 CA--C 1.541 1.7 0 C-N-CA 130.131 3.729 . . . . 0.0 114.547 -14.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.79 20.96 0.9 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 118.924 1.362 . . . . 0.0 115.181 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 -34.17 0.22 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.484 1.914 . . . . 0.0 113.145 -169.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.13 140.23 3.56 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.477 1.037 . . . . 0.0 112.478 163.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.445 ' HB3' HG23 ' A' ' 67' ' ' VAL . 37.5 m-85 -75.69 56.51 0.92 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.29 1.436 . . . . 0.0 112.787 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.53 141.64 15.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.024 -1.048 . . . . 0.0 111.67 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG22 HD11 ' A' ' 61' ' ' LEU . 29.6 m -119.16 138.52 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.295 150.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 tttp -76.66 152.21 35.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.441 1.496 . . . . 0.0 107.601 164.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -124.11 143.23 50.59 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.467 1.107 . . . . 0.0 110.366 162.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -140.76 128.27 21.36 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.3 -25.39 3.16 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.61 1.576 . . . . 0.0 113.46 172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.35 155.29 0.37 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 129.227 3.011 . . . . 0.0 116.588 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.26 162.08 15.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.224 3.283 . . . . 0.0 116.051 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -57.26 -7.62 0.58 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.047 2.539 . . . . 0.0 115.458 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.7 m -147.1 27.94 1.03 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.785 2.034 . . . . 0.0 112.099 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.5 149.91 16.26 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.022 -1.049 . . . . 0.0 110.667 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.89 165.8 24.46 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 123.294 1.521 . . . . 0.0 112.869 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 27' ' ' VAL . 55.4 t -53.03 -32.15 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 127.429 2.292 . . . . 0.0 115.174 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -75.28 -36.71 61.16 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.137 -0.977 . . . . 0.0 109.453 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 9.3 t0 -73.14 -19.22 61.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.712 1.605 . . . . 0.0 115.322 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 24' ' ' VAL . 4.8 p -86.49 -46.47 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.7 -19.2 65.62 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.579 1.952 . . . . 0.0 113.866 169.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 5.0 t30 -82.95 -48.7 10.39 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.94 2.096 . . . . 0.0 111.873 169.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -55.3 -29.53 58.39 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.589 0.756 . . . . 0.0 112.664 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 43.9 2.84 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.106 1.763 . . . . 0.0 112.314 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -56.57 -15.33 4.17 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.48 -1.691 . . . . 0.0 113.126 161.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.13 -27.11 65.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.892 2.477 . . . . 0.0 114.195 163.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.77 165.83 21.14 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -142.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.04 134.18 54.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.881 1.272 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.9 mm -114.22 156.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -100.03 112.6 24.89 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.962 1.305 . . . . 0.0 109.009 176.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.255 1.0 OUTLIER 77.14 -2.41 2.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.294 2.637 . . . . 0.0 114.557 -171.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 -60.7 3.61 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 126.037 1.78 . . . . 0.0 115.889 155.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.47 -16.94 5.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.19 2.996 . . . . 0.0 111.146 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.17 5.06 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.756 2.022 . . . . 0.0 110.595 165.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 18.13 1.84 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 126.486 1.994 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 59' ' ' VAL . 2.0 m -142.32 130.59 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 129.018 2.927 . . . . 0.0 106.011 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.547 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.9 m80 -139.36 109.59 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 108.963 -164.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -81.68 134.91 35.52 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.586 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 97' ' ' LEU . 3.4 mm -94.41 128.52 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-O 124.898 2.285 . . . . 0.0 109.31 -175.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -102.05 -159.85 0.75 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 109.508 -3.496 . . . . 0.0 107.823 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 p -135.54 172.81 12.47 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 120.461 -1.399 . . . . 0.0 110.238 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -53.65 -1.9 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 159.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.84 -0.34 9.61 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.598 2.359 . . . . 0.0 113.404 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.71 35.34 28.77 Favored Glycine 0 N--CA 1.476 1.347 0 O-C-N 120.94 -1.1 . . . . 0.0 115.179 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -147.49 135.97 21.75 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.425 1.49 . . . . 0.0 111.409 -161.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -60.13 144.7 49.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.139 0.881 . . . . 0.0 112.538 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -111.78 7.17 20.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.8 1.24 . . . . 0.0 113.249 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.72 43.77 69.39 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.804 1.192 . . . . 0.0 113.11 -167.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.91 161.51 35.03 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.626 1.17 . . . . 0.0 110.442 170.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.84 173.2 16.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.059 1.344 . . . . 0.0 110.214 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 44.9 m-85 -145.23 145.79 31.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.194 1.798 . . . . 0.0 108.586 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 43' ' ' VAL . 77.3 t -148.11 109.44 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 120.77 -1.206 . . . . 0.0 111.121 -161.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -74.83 101.62 4.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.009 1.723 . . . . 0.0 111.186 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 67' ' ' VAL . 1.3 mp -75.96 163.47 27.14 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -71.46 -14.26 74.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.155 1.836 . . . . 0.0 114.928 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -163.26 174.97 11.39 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.584 1.554 . . . . 0.0 111.958 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.78 -27.2 68.1 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.336 -0.852 . . . . 0.0 112.603 168.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -78.01 -32.15 50.96 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.99 -1.694 . . . . 0.0 110.956 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -59.68 -47.08 87.02 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.567 1.147 . . . . 0.0 112.419 162.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HA ' HD13 ' A' ' 61' ' ' LEU . 2.3 t -50.39 -53.63 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.845 1.202 . . . . 0.0 111.283 169.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -61.41 -36.76 81.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.73 -37.52 87.86 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.188 -0.945 . . . . 0.0 112.806 171.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.43 87.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.629 0.772 . . . . 0.0 112.599 172.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.01 -25.98 67.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -51.35 -29.61 15.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 120.232 1.378 . . . . 0.0 113.147 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -96.34 9.79 40.06 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.867 2.067 . . . . 0.0 114.642 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.91 5.93 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 119.778 3.251 . . . . 0.0 119.778 -161.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -154.36 17.55 0.48 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.683 1.593 . . . . 0.0 114.275 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.487 0.3 OUTLIER -84.23 -153.99 0.16 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.674 -178.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.3 p -141.04 149.32 41.54 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 121.734 2.061 . . . . 0.0 116.159 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 tpp -157.55 81.18 0.89 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.462 1.505 . . . . 0.0 110.624 168.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.66 -41.25 0.06 OUTLIER Glycine 0 N--CA 1.477 1.432 0 C-N-CA 127.893 2.663 . . . . 0.0 113.627 4.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -74.73 12.28 0.86 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.807 1.243 . . . . 0.0 112.662 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -154.54 158.44 39.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.512 2.725 . . . . 0.0 110.86 -161.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -96.51 158.26 15.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 122.949 1.357 . . . . 0.0 113.0 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.22 87.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.195 1.398 . . . . 0.0 107.364 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.19 156.04 19.34 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 159.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.9 109.9 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.51 1.124 . . . . 0.0 109.851 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 52.0 m-85 -105.17 145.05 31.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.196 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 4.4 tppp? -66.15 134.62 53.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.499 1.919 . . . . 0.0 108.596 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.5 m -154.39 177.17 11.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.835 0.854 . . . . 0.0 110.32 -166.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -135.33 174.17 10.91 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.8 0.84 . . . . 0.0 111.103 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -67.02 -42.63 84.59 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.873 -1.142 . . . . 0.0 111.982 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.0 m -65.96 -48.21 72.06 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -164.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -74.75 -32.84 62.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.224 0.92 . . . . 0.0 111.542 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.58 ' HA ' HG22 ' A' ' 96' ' ' VAL . 10.9 tmm? -56.77 -42.22 79.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.275 1.036 . . . . 0.0 112.007 175.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -15.71 63.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.543 0.737 . . . . 0.0 112.852 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -49.82 6.89 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 111.58 167.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 93' ' ' MET . 31.5 m -70.88 -20.48 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.813 -1.18 . . . . 0.0 113.825 -167.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 44' ' ' HIS . 10.1 mp -80.36 -30.0 37.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.967 1.307 . . . . 0.0 112.299 166.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -76.05 -23.39 55.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.504 1.922 . . . . 0.0 112.841 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -39.52 -28.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.907 2.083 . . . . 0.0 114.692 153.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.1 p -129.92 13.73 5.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 114.641 -173.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.13 -172.32 39.95 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--O 1.255 1.351 1 C-N-CA 125.36 4.04 . . . . 0.0 115.058 171.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 119.536 -0.269 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.8 mmm 56.33 34.45 24.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.221 1.808 . . . . 0.0 114.315 -175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.4 mt -122.25 -7.54 8.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.689 1.995 . . . . 0.0 113.77 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.69 -158.91 32.0 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 123.775 0.702 . . . . 0.0 114.259 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.93 112.68 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.977 2.451 . . . . 0.0 109.665 164.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -152.28 128.79 10.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.013 1.325 . . . . 0.0 111.296 -165.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.84 178.11 41.23 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 128.255 2.836 . . . . 0.0 109.998 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.45 -36.06 1.59 Allowed Glycine 0 N--CA 1.477 1.383 0 CA-C-N 118.231 1.015 . . . . 0.0 114.986 170.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -20.24 63.13 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.372 1.086 . . . . 0.0 111.879 157.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.43 -170.57 39.2 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.983 2.23 . . . . 0.0 111.411 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.99 42.08 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.377 2.271 . . . . 0.0 110.0 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.71 141.14 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.731 0.777 . . . . 0.0 110.115 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.38 131.51 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.962 155.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 35.7 tttp -73.03 148.65 43.92 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.898 1.679 . . . . 0.0 107.498 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 117.76 14.55 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.013 2.125 . . . . 0.0 108.354 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -133.82 136.92 44.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.592 0.757 . . . . 0.0 112.213 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.7 -28.72 6.09 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.098 0.856 . . . . 0.0 114.363 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -41.26 156.35 0.21 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 129.632 3.173 . . . . 0.0 114.219 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.97 143.3 73.47 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.671 2.914 . . . . 0.0 112.045 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -74.04 38.45 0.11 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.132 1.373 . . . . 0.0 112.772 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 m -162.51 22.75 0.1 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 128.731 2.812 . . . . 0.0 111.97 162.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.64 160.53 5.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.802 1.641 . . . . 0.0 112.848 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -145.57 170.01 17.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.298 1.523 . . . . 0.0 113.443 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG22 ' CG2' ' A' ' 43' ' ' VAL . 5.1 t -40.38 -33.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 128.419 2.688 . . . . 0.0 117.825 167.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -78.59 -12.49 60.02 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.148 -1.595 . . . . 0.0 111.651 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' ASN . 7.0 t0 -112.12 -16.27 13.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.937 2.495 . . . . 0.0 112.358 -168.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 24' ' ' VAL . 9.5 p -83.75 -39.41 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 169.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.59 -18.81 59.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.013 2.125 . . . . 0.0 114.003 169.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 16.4 t30 -69.75 -51.64 32.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.014 1.279 . . . . 0.0 111.108 161.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 83' ' ' ILE . 62.2 t80 -60.2 -38.85 84.56 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.764 -0.585 . . . . 0.0 111.476 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mt -114.77 42.13 2.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 123.167 1.461 . . . . 0.0 112.354 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -57.01 -18.16 12.72 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 112.823 -1.989 . . . . 0.0 112.193 155.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.41 -23.82 62.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.112 2.565 . . . . 0.0 115.415 162.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.69 155.21 50.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -147.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 123.89 40.99 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.403 1.081 . . . . 0.0 109.689 173.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mm -90.95 162.07 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 162.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -4.46 19.89 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.41 -54.99 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.506 1.922 . . . . 0.0 111.021 167.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.93 -42.33 1.11 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.811 1.672 . . . . 0.0 112.517 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 24' ' ' VAL . . . -128.44 -28.71 2.51 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.729 1.612 . . . . 0.0 111.141 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 17.57 0.64 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.11 -14.25 2.76 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.169 0.89 . . . . 0.0 111.694 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 24' ' ' VAL . 2.8 m -98.22 153.0 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 118.746 1.273 . . . . 0.0 111.368 -170.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 97' ' ' LEU . 3.8 m80 -149.25 148.93 30.16 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 109.42 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.54 123.93 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.39 1.076 . . . . 0.0 109.005 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.26 151.58 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 122.955 1.36 . . . . 0.0 111.391 -167.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -121.59 103.94 9.27 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.614 -148.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -54.29 -49.7 69.01 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -148.9 -38.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -123.95 -32.57 3.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -166.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.15 44.74 0.02 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -149.62 152.1 34.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.527 1.131 . . . . 0.0 112.153 -170.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -61.84 136.3 57.93 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -166.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t -93.27 178.61 5.67 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.146 0.978 . . . . 0.0 109.55 146.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.6 42.63 1.77 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 120.637 -1.289 . . . . 0.0 112.348 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.08 148.45 36.68 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.923 1.689 . . . . 0.0 111.778 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.31 170.51 16.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.382 1.873 . . . . 0.0 110.694 -170.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.657 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.0 m-85 -151.31 142.18 22.92 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.657 1.583 . . . . 0.0 108.292 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.02 108.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.426 -1.421 . . . . 0.0 111.043 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.98 95.55 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.038 1.735 . . . . 0.0 111.116 163.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.8 mt -67.79 171.63 6.31 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.99 0.9 . . . . 0.0 113.187 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.79 -6.63 72.35 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.701 1.143 . . . . 0.0 115.341 -172.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.0 p -163.13 170.97 17.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.054 2.142 . . . . 0.0 109.247 163.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 67' ' ' VAL . 2.7 tm-20 -72.3 -22.42 61.2 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.062 -1.649 . . . . 0.0 112.648 171.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -68.67 -32.12 71.72 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.265 -1.522 . . . . 0.0 111.704 168.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -57.89 -45.64 86.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.939 160.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' GLU . 4.5 m -52.89 -51.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.325 1.42 . . . . 0.0 111.874 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -53.05 -46.31 68.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.97 2.108 . . . . 0.0 114.841 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.2 mtm -65.45 -18.31 65.22 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.41 -36.9 15.21 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.936 1.295 . . . . 0.0 112.549 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mt -64.2 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.266 -1.521 . . . . 0.0 113.441 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -57.73 -21.11 39.17 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.101 -1.0 . . . . 0.0 113.028 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -103.3 8.33 38.28 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.425 2.29 . . . . 0.0 112.635 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -56.06 2.42 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -166.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.07 7.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.932 2.093 . . . . 0.0 114.373 175.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.36 0.0 OUTLIER -92.11 -166.4 1.54 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.989 0.916 . . . . 0.0 111.275 -171.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.7 p -132.22 157.59 43.95 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 119.787 -1.821 . . . . 0.0 114.499 -170.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ptm -79.87 8.11 7.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.537 1.135 . . . . 0.0 113.555 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.32 -8.53 44.7 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.612 2.053 . . . . 0.0 113.871 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -151.14 -31.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.35 157.85 45.31 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.504 1.922 . . . . 0.0 111.648 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -88.9 144.14 26.4 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 123.58 1.657 . . . . 0.0 113.526 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 30' ' ' PHE . 13.0 mm -133.97 80.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.914 -169.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -60.76 136.63 58.13 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.672 -0.643 . . . . 0.0 109.64 165.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.49 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.652 0.781 . . . . 0.0 109.363 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -105.64 150.07 25.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.547 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.23 148.09 52.29 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 164.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.0 t -149.82 172.49 15.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -136.6 156.45 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.292 0.637 . . . . 0.0 110.344 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -50.02 -43.18 50.59 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.121 1.368 . . . . 0.0 112.019 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -63.74 -44.96 91.97 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 112.82 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -70.22 -45.16 67.1 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.27 1.028 . . . . 0.0 111.303 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -56.55 -43.45 79.94 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.135 1.374 . . . . 0.0 113.086 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.07 -38.09 87.49 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.5 -1.375 . . . . 0.0 111.547 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -53.46 57.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.649 172.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.657 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 23.9 m -75.08 -27.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -167.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' HIS . 9.3 mp -70.66 -13.95 62.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -110.69 -46.87 3.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.608 1.563 . . . . 0.0 111.516 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . 0.258 1.6 t60 55.1 -36.06 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.867 3.667 . . . . 0.0 118.981 164.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -73.52 -7.85 53.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.793 1.633 . . . . 0.0 112.975 165.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.13 -176.99 46.53 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.793 1.663 . . . . 0.0 113.56 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 C-N-CA 124.898 3.732 . . . . 0.0 112.956 170.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.9 ttt -53.74 -18.98 3.59 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.72 -10.59 28.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.933 1.693 . . . . 0.0 115.106 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.5 -109.03 0.26 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.421 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.52 -178.47 3.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.367 3.378 . . . . 0.0 113.247 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -116.34 78.33 1.19 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.609 1.564 . . . . 0.0 110.21 163.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.19 64.69 0.66 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.652 2.549 . . . . 0.0 113.996 1.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 -48.04 8.02 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 118.048 1.979 . . . . 0.0 118.048 169.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.26 109.34 13.27 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 131.756 4.023 . . . . 0.0 110.801 6.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.66 -7.02 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.723 1.154 . . . . 0.0 115.807 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.76 29.62 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.304 1.552 . . . . 0.0 113.327 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.32 137.7 24.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.993 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.79 127.86 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.351 154.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.628 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 28.1 tttp -73.8 144.6 45.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.14 131.58 50.74 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.683 1.593 . . . . 0.0 108.683 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -139.07 125.75 20.72 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.63 -29.04 3.18 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 125.226 1.393 . . . . 0.0 113.49 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -37.13 158.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 130.479 3.511 . . . . 0.0 116.868 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.89 146.26 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 113.246 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 17.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.0 m -144.37 21.11 1.71 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.033 2.133 . . . . 0.0 112.073 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.44 152.69 14.03 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.561 1.145 . . . . 0.0 112.341 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -146.01 169.81 17.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 123.34 1.543 . . . . 0.0 112.772 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CG2' ' A' ' 43' ' ' VAL . 2.9 t -40.41 -34.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 164.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -75.39 -34.42 61.09 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.738 -1.851 . . . . 0.0 110.075 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -28.34 62.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.998 3.319 . . . . 0.0 113.752 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 24' ' ' VAL . 2.4 p -86.84 -28.83 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 122.813 1.292 . . . . 0.0 108.589 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.27 -28.49 27.15 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 129.045 2.938 . . . . 0.0 111.32 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.95 -43.03 72.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.798 1.639 . . . . 0.0 111.868 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -59.82 -35.06 73.94 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.296 0.498 . . . . 0.0 111.717 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.28 50.33 1.05 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 123.308 1.528 . . . . 0.0 111.71 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.0 p -49.55 -26.31 3.4 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 111.998 -2.364 . . . . 0.0 112.185 166.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.41 -20.27 62.14 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.362 3.865 . . . . 0.0 114.302 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.13 150.96 51.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -144.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.84 120.09 33.64 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.081 1.352 . . . . 0.0 108.912 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 1.7 mp -88.01 153.21 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 154.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 50.6 t-80 -63.9 6.68 0.15 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -163.75 -56.37 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.291 2.636 . . . . 0.0 110.546 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.6 -42.22 1.09 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.821 2.153 . . . . 0.0 112.656 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.18 -26.71 3.06 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 111.134 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.22 13.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.36 -13.68 8.78 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 24' ' ' VAL . 1.6 m -88.38 149.31 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 124.752 1.221 . . . . 0.0 111.244 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.473 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.4 m80 -147.42 153.53 39.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.482 1.913 . . . . 0.0 108.02 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -127.76 145.9 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.543 0.737 . . . . 0.0 109.477 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.89 143.4 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 123.645 1.688 . . . . 0.0 107.94 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.45 119.5 16.49 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 111.559 -2.564 . . . . 0.0 106.774 -156.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.5 p -64.6 166.09 9.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.564 0.746 . . . . 0.0 110.815 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -66.68 -4.4 8.77 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.03 -5.43 10.53 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.744 1.618 . . . . 0.0 114.805 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 58.88 0.49 Allowed Glycine 0 N--CA 1.475 1.253 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 164.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.8 ttm105 -148.4 147.64 29.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.82 1.648 . . . . 0.0 111.058 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -57.27 126.9 29.33 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.201 0.909 . . . . 0.0 111.044 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -81.73 9.52 7.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.334 1.453 . . . . 0.0 114.202 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.53 37.34 49.55 Favored Glycine 0 N--CA 1.471 1.025 0 O-C-N 121.235 -0.916 . . . . 0.0 112.333 -157.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.44 146.05 34.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.37 1.468 . . . . 0.0 110.467 173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.16 169.18 22.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.439 1.496 . . . . 0.0 110.824 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 42.4 m-85 -145.56 137.06 25.13 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.036 1.334 . . . . 0.0 108.739 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.51 101.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.401 -1.437 . . . . 0.0 110.535 -166.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.24 94.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.28 1.832 . . . . 0.0 111.428 163.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 10.1 mt -65.55 176.13 1.58 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.042 0.937 . . . . 0.0 112.395 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 37' ' ' HIS . . . -96.02 -0.75 61.69 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.658 -1.276 . . . . 0.0 115.216 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.2 p -164.9 177.4 7.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.193 2.197 . . . . 0.0 110.529 160.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -86.25 -9.64 56.11 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.077 -1.639 . . . . 0.0 113.02 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -75.51 -31.51 60.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.059 -1.651 . . . . 0.0 110.963 158.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -60.07 -47.73 84.65 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.559 -1.21 . . . . 0.0 111.616 160.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 10.4 m -54.36 -48.99 67.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 120.851 1.66 . . . . 0.0 112.69 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -53.65 -44.79 69.9 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.909 2.083 . . . . 0.0 114.299 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 36.2 mtm -65.36 -19.51 65.98 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.07 -32.25 17.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 113.973 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.85 -32.65 74.06 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 119.798 -1.814 . . . . 0.0 113.096 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -61.15 -21.4 63.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -90.15 -0.04 57.41 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.082 2.153 . . . . 0.0 113.799 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.98 16.09 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 120.6 3.555 . . . . 0.0 120.6 -162.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.5 10.49 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.409 2.684 . . . . 0.0 113.958 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . 0.424 0.0 OUTLIER -94.41 -155.32 0.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.498 0.719 . . . . 0.0 111.683 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -137.86 147.96 44.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -158.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 34.2 tpp -151.85 131.98 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.187 1.395 . . . . 0.0 109.921 163.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.41 -163.12 52.73 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.72 0.676 . . . . 0.0 112.249 -160.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -70.51 28.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.223 1.809 . . . . 0.0 113.454 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -153.08 163.86 39.07 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.801 1.64 . . . . 0.0 112.639 -140.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -117.5 155.41 29.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 113.04 -174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.66 88.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.633 1.173 . . . . 0.0 109.049 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -64.42 134.28 54.22 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.066 -1.021 . . . . 0.0 108.686 161.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -118.53 115.87 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.118 0.961 . . . . 0.0 110.187 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.7 m-85 -103.11 152.08 21.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.656 0.741 . . . . 0.0 109.796 172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -79.71 134.36 36.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.229 1.812 . . . . 0.0 106.934 166.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HE2' ' A' ' 87' ' ' LYS . 28.8 t -137.44 162.99 32.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.414 1.485 . . . . 0.0 109.244 -167.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -134.6 172.4 12.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.916 0.887 . . . . 0.0 110.143 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -56.0 -47.4 77.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.774 -1.107 . . . . 0.0 112.686 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -86.37 131.34 34.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 145.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 0.09 56.24 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 133.449 4.7 . . . . 0.0 115.479 11.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -57.74 -39.73 78.02 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.748 1.158 . . . . 0.0 113.81 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.24 -36.55 84.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.953 0.901 . . . . 0.0 112.135 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.76 -56.87 16.39 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.884 1.673 . . . . 0.0 109.888 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 34.3 m -75.7 -23.45 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -159.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' HIS . 11.0 mp -75.09 -37.55 61.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.474 1.11 . . . . 0.0 112.635 168.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -73.03 -47.63 43.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.884 1.274 . . . . 0.0 111.633 -175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 28.25 62.22 0.12 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.84 2.456 . . . . 0.0 114.879 159.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.5 t -129.72 147.55 51.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.239 2.616 . . . . 0.0 111.723 1.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.97 175.87 46.97 Favored Glycine 0 CA--C 1.544 1.868 0 C-N-CA 125.416 1.484 . . . . 0.0 113.643 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.829 3.686 . . . . 0.0 113.008 -177.474 . . . . . . . . 0 0 . 1 stop_ save_